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Structure and Function of the Murine Lymph Node       
Lymph nodes (LNs) are dynamic organs responsible for providing a supportive and centralized 
environment for the generation of immune response. Utilizing a highly organized network of 
non-hematopoietic stromal cells, the LN serves as the context in which the immune system 
collects and presents antigen, promotes innate and adaptive immune interaction, and generates 
protective cell-mediated and humoral immunity. In this way, proper organization and function of 
the LN environment is a critical component of effective immunity, and understanding its 
complexity has direct impact on the ability to generate and modulate primary immune response 
to specific antigens. To this end, the LN architecture, underlying stromal networks, and 
environmental and cellular responses to influenza vaccination were investigated. Using novel 
approaches to conduit imaging, details of the collagen network that comprises the LN 
scaffolding have been integrated into current understandings of LN architecture. The cellular 
compartment responsible for the maintenance of that scaffolding, fibroblastic reticular cells 
(FRCs), have been studied using an induced diptheria toxin receptor model. By specifically 
ablating the FRC population in mice, their role in the maintenance of T cell homeostasis has 
been confirmed in vivo. More surprisingly, a disruption of the FRC network resulted in a loss of 
B cell follicle structure within LNs, and a reduction in humoral immunity to influenza vaccination. 
These findings led to the identification of a new subset of FRCs which reside in B cell follicles, 
and serve as a critical source of the B cell survival factor BAFF. Turning towards the 
hematopoietic response to influenza vaccination, a highly unexpected lymph node resident 
dendritic cell (LNDC) response has been identified following vaccine antigen deposition within 
specialized sites in the LN medulla. Rapid migration of LNDCs into these sites optimizes 
exposure of the population to viral antigen, and de novo synthesis of a CXCL10 chemokine  
iiigradient by activated LNDCs ensures efficient antigen specific CD4+ T cell response, and 
protective humoral immunity –  independent of migratory dendritic cell status. Altogether, these 
studies highlight a highly dynamic, responsive LN environment with direct influence on primary 
immune response – the understanding of which has broad implications in vaccine biology. 
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 1Chapter 1.1 – Circulatory dynamics 
 
   On an average day, an adult human pumps roughly 5L of blood through almost 
100,000km of vasculature at a rate of 5L/min. Although exact measurements are inherently 
difficult to obtain, it is likely that at any given moment the total blood volume is contained within 
800 and 1000m2 of capillary bed where it is responsible for oxygen and nutrient exchange with 
local tissue to maintain a homeostatic tissue environment. While it is likely that few cells in the 
body are separated from a feeding capillary by more than 50µm, the tissue remains physically 
separated from the vessel lumen due to the tight junctions carefully maintained by the blood 
endothelial cells (BECs) that make up the vessel wall(Cliff, 1976). Although this physical barrier 
is capable of retaining cells in the lumen, it is not entirely impermeable to small molecule 
exchange and the slow leakage of plasma driven into the surrounding tissue by positive 
intravascular pressure and osmotic gradients(Casley-Smith, 1985). This interstitial fluid bathes 
the surrounding tissue, and its constant flow through the extracellular space carries away 
processed metabolites while maintaining a constant pH and providing the raw materials required 
for cellular homeostasis. 
  Due to the nature of this interstitial fluid flow, a scavenging system is required to remove 
excess fluid and serum protein (such as albumen) as it builds in the tissue to maintain osmotic 
homeostasis across the vessel wall. This scavenging system, known as the lymphatic system, 
serves as an outlet for the constant pumping of interstitial fluid into the tissue, and is ultimately 
responsible for the recycling of blood volume and albumin lost from the cardiovascular system. 
This process of fluid and metabolite removal is carried out through a complementary lymphatic 
vascular system largely comprised of highly organized lymphatic endothelial cells(LECs) (Chen 
et al., 2014). Unlike BECs, LECs do not exclusively form tight junctions, but instead form 
lymphatic vessels with primary valve-like structures allowing unidirectional fluid flow from the 
interstitial space into lymphatic capillaries(Schmid-Schönbein, 2003; Trzewik et al., 2001; 
Mendoza and Schmid-Schönbein, 2003). This unique structure, along with unidirectional valves 
 2within the lymphatic vessels themselves, ensures that excess interstitial fluid can be effectively 
sequestered from the extracellular space, and directionally carried away as lymph to make room 
for fresh fluid to bathe the tissue(Hudack and McMaster, 1932). From the lymphatic capillaries, 
collected lymph is transported to less permeable collecting vessels(Baluk et al., 2007), and 
eventually into the thoracic duct which merges with the left subclavian vein, returning lost blood 
volume back into circulation. 
  This system of nutrient distribution and fluid recycling poses a significant theoretical 
problem when addressing the threat of infectious disease. Supposing a barrier breach in 
peripheral tissue (say a cut on the hand), and subsequent bacterial infection, the extracellular 
bacteria is bathed in the same interstitial fluid which is designed to feed the tissue under 
homeostatic conditions. While many pathogens are highly tissue tropic, overwhelming infection 
and high infectious titers could easily lead to the collection of bacteria into the lymphatic system 
along with interstitial fluid to be eventually recycled. Unrestricted, this lymph-born bacteria would 
travel through the lymphatic system into the thoracic duct, where it would eventually merge into 
active circulation. In this way, a bacterial infection initially restricted to the hand could quickly 
turn into a much more serious blood-borne infection leading to septicemia, toxic shock 
syndrome, and multi-organ failure. To prevent this scenario, the lymph is filtered to remove 
infectious material at several critical points in its journey from the periphery to the thoracic duct. 
These filtration points are referred to as lymph nodes.  
 
 
Chapter 1.2 – Lymphatic structures of the lymph node 
   
  Lymph nodes (LNs) are small organs which are scattered along the strings of lymphatic 
vessels, beginning in the periphery, and leading to the thoracic duct. Each lymph node functions 
independently along the string, although they are often found in series such that lymph flows 
 3from one LN to the next before finally rejoining 
circulation. Lymph vessels carrying lymph into 
a LN are referred to as afferent lymphatics, 
whereas vessels leading away from the node 
are termed efferent. As lymph enters the node 
through the afferent lymphatics, it first arrives 
in the subcapsular sinus (SCS) – a flat sinus 
residing just under the collagen capsule which 
comprises the outer boundary between the LN 
and the surrounding environment(Heath et al., 
1986; Fossum, 1980a). While the dense 
collagen capsule of the LN demarcates the 
upper boundary of the SCS, a finer, more 
reticular lateral network of collagen bundles 
can be identified as the structural scaffolding of 
the SCS floor. Both the capsule and lateral 
reticular network can be conveniently labeled 
and visualized through subcutaneous injection 
of soluble fluorescein isothiocyanate (FITC) 
upstream of the draining LN (Fig 1).  
  The SCS is physically contiguous with the incoming afferent lymphatics, with the walls of 
the afferent lymphatics merging into the LN capsule. The luminal space is punctuated with 
collagen ‘spacers’ which span across the 0-20um lumen(Ohtani and Ohtani, 2008), and are 
directly attached to both the outer collagen capsule and lateral reticular floor (Fig 1a,b). While 
the SCS is generally appreciated as a single lymph filled sheet draping the LN cortex, 
inconsistency of collagen spacer lengths, and the apparent periodic merging of the SCS floor 
 4
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Figure 1 – Collagen structure of the subcapsular 
sinus floor. (a,b) C57BL/6 mice were in vivo labeled 
with PBS-FITC. PLNs were harvested, fixed, and 
optically cleared. LNs imaged by MPM, with second 
harmonics shown. Orange arrows – collagen 
spacers(c) Same as in [a,b], except mice were in vivo 
labeled with a-CD169. LN imaged by confocal 
microscopy following thin cryosectioning. Heavy dash 
- collagen capsule; light dash – lateral collagen matrix. 
Magenta arrow – capsule and lateral collagen network 
mergingwith the outer collagen capsule 
as visualized by FITC painting 
suggests that this interpretation 
may be incorrect (Fig 1c). 
Instead, an alternative model 
could be proposed where only 
specific sections of the SCS 
actually contain a luminal space 
contiguous with the upstream 
afferent lymphatics. More data is 
needed to confirm this view of 
the SCS structure, and 
understand the importance of 
this configuration in lymph node 
development, filtration, and 
immune response. 
  While the collagen structure 
provides the scaffolding for the 
SCS, CD31-Podoplanin+Lyve-1+ LECs are required to form the cellular barrier surrounding the 
luminal space(Chen et al., 2014). Recent studies have shown that there is a stratification of 
function in these LECs, currently typified by differential chemokine receptor expression 
(discussed later), which is dependent on their residence in the floor (paremchymal side, fLECs) 
or ceiling (capsular side, cLECs) of the SCS lumen (Ulvmar et al., 2014). Injection of soluble 
fluorescein isothiocyanate (FITC) into Prox-1-tdTomato fluorescent reporter mouse (a master 
regulator of lymphatic vessel development) reveals attachment of cLECs to the outer collagen 
capsule, while fLECs are seen embedded into the lateral collagen matrix in the SCS floor (Fig 
2a). Somewhat surprisingly, while Prox1+ LECs can be identified surrounding the SCS lumen, 
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Figure 2 – Lymph node stroma in the subcapsular sinus. (a,b) 
Prox1 x tdTomato reporter mice were in vivo labeled with PBS-FITC. 
PLNs were harvested, fixed, and optically cleared. LNs imaged by 
MPM. Heavy dash - collagen capsule; light dash – lateral collagen 
matrix; Orange arrows– cLECs; Magenta arrows – fLECs (c) 
C57BL/6 mice were in vivo labeled with PBS-FITC. PLNs were 
harvested, fixed, and cryosectioned. Sections imaged by confocal 
microscopy. they appear discontinuous on the 
sinus lining, raising interesting 
questions about the possibility of 
multiple populations responsible for 
SCS barrier integrity (Fig 2b). 
Further, localization of MadCAM-1 
positive cells wrapped around the 
collagen floor and spacers(Katakai, 
2012) in the SCS further suggests 
that the exact identities of these 
stromal barrier cells may remain yet 
unclear (Fig 2c) 
As the lymphatics that make up the 
SCS approach the efferent side of 
the LN, they begin to branch, and 
form a highly complex labrynth of 
lymphatic vessels known collectively 
as the medulla(Ohtani and Ohtani, 
2008) (Fig 3).Similar to the SCS, 
the lymphatic vessels that comprise 
the medulla are surrounded by a 
reticular collagen network, and 
contain collagen bundles that 
extend across the luminal space (Fig 3). The cellular boundaries of the medullary lymphatic 
vessels are similarly maintained by Lyve-1+ LECs, although specialization within this population 
remains yet undocumented. As lymph flows from afferent to efferent, the medullary lymphatics 
merge together, and ultimately leave the node as a single vessel to form the efferent lymphatic. 
 6Once in the efferent lymphatic, lymph will either travel to the next LN in the string, or return to 
circulation via the thoracic duct. 
 
 
Chapter 1.3 – Filtration of lymph in the lymph node   
  Alternative to the physical and enzymatic means by which the kidneys and liver perform 
their filter functions, the filtration of pathogens and debris in the lymph node relies almost 
exclusively on phagocytosis and lysosomal degradation by lymph node resident macrophages. 
Although several populations of specialized macrophages exist within the LN, two appear to be 
particularly important in protection from infection, and active filtration of the lymph(Gray and 
Cyster, 2012).  
The first population, resident in the SCS (termed subcapsular sinus macrophages 
[SSMs]), are exposed to the first wave of antigen that flows from the afferent lymphatics into the 
LN, and are characterized by their CD11bhi F4/80- CD169+ expression pattern (Martinez-
Pomares and Gordon, 2012). Electron microscopy and fluorescent imaging have identified SSM 
cell bodies on both the luminal, and parenchymal side of the SCS floor(Farr et al., 1980; Junt et 
al., 2007; Phan et al., 2007). In either case, SSMs have been shown to cast stable projections 
across the floor, so that they are directly exposed to the afferent lymph. Although these cells are 
proficient in the uptake of antigen, they are described as having low levels of phagocytic and 
degradative potential(CLARK, 1962; Nossal et al., 1965; Fossum, 1980a). Instead, SSMs are 
primarily implicated in transfer of intact-antigen hand off to underlying B cells in a process that 
will be described later. Interestingly, recent studies of this population have suggested that SSMs 
are highly susceptible to viral infection, but respond robustly to infection through the production 
of large quantities of type I interferons (Moseman et al., 2012; Iannacone et al., 2010). These 
data suggest that while SSMs may have little effect on overall lymph filtration due to low antigen 
 7turnover, their specialized functions may be critical in responding to certain types of peripheral 
infection. 
More relevant to the filtration of lymph in the LN, CD11bhi F4/80+ CD169+ SIGNR-1+ 
medullary sinus macrophages (MMs) densely pack the labyrinth of lymphatic vessels that make 
up the medulla(Gray and Cyster, 2012). Anatomically, MMs are found attached to the lymphatic 
vessel wall or residing on the reticular fibers that cross the vessel lumen(Takahashi et al., 1998; 
Fossum, 1980b; Fossum and Vaaland, 1983). Unlike SSMs, MMs are highly phagocytic, and 
skewed towards non-specific degradation of antigen. This system of filtration is surprisingly 
efficient, and multiple studies have identified the medulla as the primary concentration point of 
antigen arriving through the lymphatics suggesting a broad spectrum of binding 
specificities(Fossum, 1980a; Steer and Foot, 1987; Gonzalez et al., 2010). Following MM 
disruption with cholodrinate loaded liposomes, injected antigen can be found in subsequent 
downstream LNs, highlighting their importance in maintaining a sterile lymph environment 
(Gonzalez et al., 2010). Interestingly, recent unpublished work has suggested that the human 
adjuvant, MF59, leads to a disruption of the MM population in mice, coinciding with humoral 
responses in non-draining LNs. 
  Due to their placement along the lymphatic vasculature, each individual LN is 
responsible for the filtration of a specific area of the organism. One example, the popliteal LN (a 
focus of this study), is situated directly behind the knee and serves as the first filtration point for 
every lymph-borne particle originating in the foot or lower leg. In the case of infection, any 
lymph-borne infectious material will accumulate in the local LN, but be absent from the 
downstream node. In this way, subcutaneous administration of infectious material in the foot will 
result in antigen accumulation only in the popliteal LN (PLN). The result of this configuration is 
that each individual lymph node will be bathed in cell debris, spent metabolites and any 
infectious antigen originating from the tissue which they drain. As the adaptive immune system 
requires exposure to foreign antigen in order to respond, the LN provides a convenient location 
for the adaptive immune system to effectively survey the upstream tissue for infection.  
 8Chapter 1.4 – Organization of the lymph node 
 
  To accommodate adaptive immune surveillance, the parenchyma of the LN (which is 
compartmentally separated from the lymphatic lumen by lymphatic endothelial barriers) provides 
a range of functions to direct lymphocyte recruitment, support lymphocyte survival, and facilitate 
innate and adaptive immune interactions. Broadly, the parenchyma of the LN can be broken 
down into two compartments – the T cell zone (the paracortex) and the B cell zone (the cortex) 
(Fig 3). These two compartments, although lacking a physical boundary between them, are 
nonetheless highly organized and independently controlled through the maintenance of 
chemokine gradients(Ansel et al., 2000). 
  Chemokines are a family of small cytokines between 8 and 10 kD primarily named for 
their ability to induce directional cell migration. Although 4 subfamilies exist with slightly different 
primary structures (CC, CXC, XC, and CX3C), almost all have similar function in binding specific 
7-transmembrane, G-coupled protein receptors often named for the type of chemokine that they 
bind (ie. CCR, CXCR, XCR and CX3CR)(Rollins, 1997). These chemokine/chemokine receptor 
interactions result in leukocyte calcium flux, integrin activation and cellular migration towards 
increasing concentrations of the chemokine signal(Springer, 1994; 1995; Butcher, 1991). By 
establishing multiple, complex gradients, and restricting expression of specific chemokine 
receptors to different immune cell types, the immune system is organized within the lymph node 
without need of physical barriers(Ansel et al., 2000)(Fig 3). This method of organization allows 
geographical flexibility in that a change of receptor expression on the surface of a lymphocyte 
can direct it to a different compartment within the node(Breitfeld et al., 2000; Kim et al., 2001). 
Alternatively, this study identifies the establishment of a new chemokine gradient within the 
lymph node to quickly and efficiently reorganize an immune response to promote interaction 
between specific cell types. 
  The paracortex of the LN, characterized by the expression of the chemokines CCL19 
and CCL21(Gunn et al., 1998; Dieu et al., 1998; Luther et al., 2000), represents the more 
 9efferent side of the LN parenchyma, although it is physically separated from the medullary 
lumen. CCR7, the receptor responsible for CCL19/21 recognition, is expressed at high levels on 
naïve T cells, resulting in high concentrations of T cells within the paracortex(Förster et al., 
1999). Thus, the paracortex is often referred to as the ‘T cell zone’. Importantly, the paracortex 
also serves as an entryway to incoming naïve lymphocytes looking to survey the node. High 
endothelial venules (HEVs), specialized blood vessels which are required for lymphocyte 
ingress, can be found punctuated throughout the compartment(Girard and Springer, 1995, Fig.
3). Decoration of the luminal side of HEVs with the paracortical chemokines CCL19/21 
facilitates a critical step in the rolling adhesion cascade resulting in LN homing(Baekkevold et 
al., 2001; Andrian and Mempel, 2003). 
Similarly to the paracortex, the cortex is physically separated from the lymphatic lumen 
by lymphatic endothelial barriers. The cortex, however, is characterized by expression of the 
chemokine CXCL13 rather than CCL19/21(Ansel et al., 2000), and is found on the afferent side 
of the node directly under the SCS. The receptor for CXCL13, CXCR5, is highly expressed on 
naïve B cells resulting in the demarcation of the ‘B cell zone’. It is worth noting, however, that 
naïve B cells first entering the node express high levels of CCR7, and like T cells, utilize the 
HEV network in the paracortex for LN entry(Girard and Springer, 1995). Over the course of a 
normal humoral response, both lymphocyte populations are capable of altering their chemokine 
receptor expression (ie. B cells upregulating CCR7, and traveling to the cortical/paracortical 
junction) in order to facilitate cellular interactions important in the generation of immune 
response(Okada and Cyster, 2006; Pereira et al., 2010; Nurieva and Chung, 2010). In this way, 
organization of the immune system through chemokine gradients rather than physical barriers 
allows flexibility of cellular interaction, while maintaining separation and specialized function. 
This system of differential chemokine gradient expression is controlled largely by the specific 
stromal subsets that also inhabit the T and B cell zones. 
 10    The largest stromal component of the LN parenchyma is the fibroblastic reticular cell 
(FRC) network. Characterized as CD45- GP38+ CD31- (Malhotra et al., 2012a), FRCs form 
extensive networks which provide migratory traction to the more motile hematopoietic 
compartment (Bajénoff et al., 2007; Lämmermann and Sixt, 2008). Additionally, these cells are 
responsible for the structural maintenance of the LN environment through the production of the 
collagen conduit network (Gretz et al., 1997; Mueller and Germain, 2010; Turley et al., 2010; 
Katakai et al., 2004), and have been recently described to interact directly with the 
hematopoietic compartment to regulate T cell homeostasis and response (Link et al., 2007; 
Lukacs-Kornek et al., 2011; Saini et al., 2009; Pellegrini et al., 2011). As the major producers of 
CCL19 and 21 within the paracortex, FRCs are responsible for producing and maintaining the 
chemokine gradients required for the persistence of the T cell zone. FRC function in immune 
homeostasis and response is a critical component of this study, and will be discussed in detail 
later. 
  While FRCs have been identified in the B cell zone, their importance in the structure and 
maintenance of the cortex has remained unclear. Although this study attempts to clarify the role 
of FRCs in B cell follicles, the integrity of the B cell compartment has been attributed to an 
independent stromal compartment known as follicular dendritic cells (FDCs)(Heesters et al., 
2014). These non-hematopoietic cells (CD45- CD35+ GP38+ CD31-) form dense dendrite 
networks which wrap the collagen reticular fibers throughout the cortex(Cyster et al., 2003), 
similarly to FRCs in the paracortex. In addition to producing the follicle specific chemokine 
CXCL13(Ansel et al., 2000), they have also been reported to express the B cell anti-apoptotic 
factor BAFF(Garin et al., 2010; Wu et al., 2009), highlighting their importance in both 
organization and survival of the B cell compartment within LNs. In addition to their function at 
steady state, FDCs are also highly specialized in the retention of large protein antigen(Mandel 
et al., 1980), and are critical for the formation of germinal centers in the establishment of 
humoral immune response(Kelsoe, 1996; MacLennan, 1994; Allen and Cyster, 2008). 
 11Although FRCs and FDCs have been considered the major contributors to the 
establishment of chemokine gradients within the LN, cLECs have also been shown to help 
groom the chemokine gradient by sequestering excess CCL19 and 21 through the non-
signalling receptor CCRL1, thereby serving as a chemokine ‘sink’ (Ulvmar et al., 2014). This 
finding, in accordance with previous reports identifying direct CCL21 expression by LECs in the 
afferent lymphatics as a mediator of lymphocyte homing suggests that these cells might also 
play an important role in lymph node organization and homeostasis (Stein et al., 2000). 
Altogether, these three stromal subsets (LECs, FRCs, and FDCs) work in concert to ensure the 
clear delineation of the cortical/paracortical junction through chemokine expression and 
regulation, and their proper function is critical in generating effective immune response(Malhotra 
et al., 2012a). 
 
 
Chapter 1.5 – Antigen acquisition within the lymph node 
 
  While the parenchyma of the lymph node is contiguous, and allows for free travel 
between the B cell and T cell zones, so long as the correct chemokine receptors are expressed, 
the physical barrier between the parenchyma and the lumen of the lymphatics presents a 
unique challenge in generating protective humoral immune responses. As this barrier prevents 
direct encounter of lymphocytes with foreign antigen in the lymph environment, the antigen must 
find it’s way into the LN parenchyma where the adaptive immune system can detect it and 
respond accordingly (Gonzalez et al., 2011). Especially in the case of B cells which must see 
intact antigen for effective response, it is critical for antigen at distal infected sites to find its way 
into the draining LN relatively intact. This challenge in antigen transport into the node is 
overcome through four independent mechanisms: 1. Dendritic cell (DC) transport from the 
 12periphery; 2. Low molecular weight transport through conduits; 3. SSM antigen transport; 4. 
Direct antigen capture by lymph node resident dendritic cells (LNDCs). 
  Dendritic cells are highly specialized antigen presenting cells residing in almost all 
tissues in men and mice(Steinman, 1991). While in their resident tissue they are relatively 
sessile and inactive, they respond robustly to both pathogen associated molecular patterns 
(PAMPs) and danger associated molecular patterns (DAMPs) by quickly scanning the local 
environment for pathogens(Rescigno et al., 1997).  By increasing phago- and pinocytosis, they 
rapidly uptake pathogens in the interstitial fluid, and effectively take a ‘snapshot’ of their local 
environment(Austyn, 1996; Alvarez et al., 2008). Having picked up potentially infectious material 
in their resident tissue, DCs become highly active and capable of performing their antigen 
presenting functions required for the establishment of adaptive immunity(Alvarez et al., 2008). 
By remodeling the local extracellular matrix(Yen et al., 2008), and following a CCL21 gradient 
via the chemokine receptor CCR7(Weber et al., 2013), activated DCs leave their resident tissue, 
migrate through the afferent lymphatics in integrin dependent or independent mechanisms(Platt 
and Randolph, 2013; Schmidt and Friedl, 2010; Lämmermann et al., 2008), and ultimately arrive 
in the SCS of the draining LN (Förster et al., 1999; Ohl et al., 2004; Förster et al., 2008; Braun 
et al., 2011). Once there, DCs cross the SCS floor utilizing a carefully groomed CCL19/21 
gradient, and enter the paracortex where they then interact with antigen specific T cells to 
initiate adaptive immunity (Ulvmar et al., 2014). In this way, migratory DCs are capable of 
recognizing potentially pathogenic antigen in the periphery, and actively transporting it into the 
draining LN – thus bypassing the barrier problem. 
  In addition to the active transport of antigen to the LN by migratory DCs, any pathogen 
or small molecule which is released into the interstitial fluid of the periphery will be carried to the 
draining LN through normal lymphatic flow(Kissenpfennig et al., 2005). Leaving the tissue, 
antigen is collected into lymphatic capillaries, and eventually drains into the SCS as previously 
described. In the SCS, antigen flows through a luminal space spanning 0-20µm, packed with 
subcapsular sinus macrophages(Farr et al., 1980; Junt et al., 2007; Phan et al., 2007). While 
 13the floor of the SCS is made of LECs which are largely impermeable to antigen escape, the floor 
is punctuated with collagen conduits which serve as a shortcut for fluid to flow into the 
parenchyma of the LN(Roozendaal et al., 2009).  
  Collagen is by far the most abundant protein in humans, accounting for one third of total 
protein, and three quarters of the dry weight of skin (Shoulders and Raines, 2009). While at 
least 28 independent types of collagen have been identified in vertebrates, all share a common 
repeating XaaYaaGly polypeptide sequence flanked by N and C terminal pro-
peptides(Shoulders and Raines, 2009). Each individual polypeptide chain forms a tight left-
handed helix mediated by the repeating glycine residues(Okuyama, 2008). Once secondary 
structure is established, the flanking pro-peptides allow for assembly of three parallel 
polypeptide strands into a right-handed triple helix(Berisio et al., 2002; Wess et al., 1998; Traub 
et al., 1969). The propeptides are then trimmed from the triple-helices, which then self assemble 
into larger collagen microfibrils. Finally, microfibrils are cross-linked to form dense collagen 
fibers up to 500nm in diameter (Shoulders and Raines, 2009). After assembly of these individual 
collagen fibers, multiple fibers can be packaged together into much larger bundles for increased 
strength. While individual fibers are dense and highly cross-linked, bundles of fibers are less 
tightly associated. This more loose configuration allows for fluid and small molecule penetration 
of the fibers, which can then travel the length of the bundle freely. In the lymph node 
environment, this interesting property allows collagen bundles to act as conduits of lymph flow 
directly through the cortical and paracortical regions which are otherwise largely 
impermeable(Roozendaal et al., 2009; Sixt et al., 2005; Gretz et al., 2000). 
Conduits, which are reported to be secreted by FRCs, initiate at the SCS lateral collagen 
matrix floor, often as extensions of the SCS collagen spacers, and extend throughout the LN 
before emptying back into the efferent lymph or HEVs (Fig 4). The dense, bundled collagen 
structure of conduits ensures that only small molecules under ~70kD (Gretz et al., 2000)have 
direct access to the B cell follicles underlying the SCS floor(Roozendaal et al., 2009).  Once in 
conduits, antigen can be directly sampled by naïve B cells and FDCs in the LN leading to the 
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are usually found wrapped by FRCs throughout 
the LN(Anderson and Anderson, 1975; Anderson 
and Shaw, 1993; Kaldjian et al., 2001), 
transmission electron microscopy has revealed 
fine dendrites of FDCs reaching through the 
FRC layer and directly into the collagen 
bundle(Roozendaal et al., 2009). Antigen 
specific B cells display rapid acquisition of 
cognate antigen via this conduit mechanism 
within minutes of antigen injection upstream of 
the draining LN, ultimately resulting in 
downstream humoral immunity(Roozendaal et 
al., 2009). In addition to serving as pathways for 
lymph flow, this dense collagen network also 
serves as a substrate for hematopoietic motility 
within the LN environment(Bajénoff et al., 2007; 
Lämmermann and Sixt, 2008). 
  Rather than entering the conduit system, antigen larger than 70kD is forced to flow 
through the SCS where it will eventually drain into the medulla, and ultimately, the efferent 
lymph. Due its dense nature, draining antigen is in direct contact with SSMs within the luminal 
space. Additionally, SSMs have been described to be situated underneath the SCS floor, 
sending projections into the lumen to ‘sample’ the lymph flowing past(Berney et al., 1999; 
Martinez-Pomares et al., 1996). While SSMs are not particularly phagocytic, they are highly 
specialized in capturing soluble antigen in the lymph, particularly opsonized antigen through 
complement receptor 3 (CD11b/CD18), and actively transporting it intact across the SCS 
floor(Phan et al., 2007; Junt et al., 2007; Carrasco and Batista, 2007). Once transported, 
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receptor 2 [CD21]), or BCR specific manner(Junt et al., 2007; Phan et al., 2007). B cells that 
have acquired antigen from SSMs can then transfer it to FDCs via complement receptors where 
it can be retained for the establishment of a germinal center response. This method of antigen 
transport is especially enticing due to its ability to protect the native epitopes present in complex 
antigen which could then be used for effective humoral immunity(Phan et al., 2007). 
  Despite the efficient capture of complement fixed antigen by SSMs, their low phagocytic 
potential and tendency to protect –rather than degrade – complex protein antigen renders them 
less useful in large scale filtration of the lymph. In cases where antigen is abundant, such as 
vaccination, large amounts of antigen rapidly flows through the SCS and is collected in the 
medulla(Fossum, 1980a; Steer and Foot, 1987; Gonzalez et al., 2010). Here, MMs quickly 
sequester and degrade macromolecules and pathogens. While these cells are critical for filter 
function in the LN, they are less well described in their contribution to antigen transport, or 
presentation to the adaptive immune compartment. These macrophages, however, are 
interspersed with small numbers of resident DCs which are more equipped to make use of 
antigen filtered in the medulla(Gonzalez et al., 2010). 
  As with most peripheral tissues, the LN environment is home to specific DC subsets 
referred to as lymph node resident DCs. The LNDC compartment is primarily comprised of 
‘conventional’ DCs which can be broken down further into CD8a+ (CD11bint-neg CD11chi CD8a
+CD4-), CD11bhi (CD11bhi CD11chi CD8a-CD4+), and double negative (CD11bhi CD11chi CD8a-
CD4-) cDCs(Dudziak et al., 2007; Shortman and Heath, 2010; Villadangos and Schnorrer, 
2007). In addition, migratory DCs (both dermal DCs and langerhaans cells) which constitutively 
migrate in from the periphery are present in the LN, and seem important for the maintenance of 
peripheral tolerance(Igyártó et al., 2011; Helft et al., 2010; Heath and Carbone, 2009; Hawiger 
et al., 2001). While the importance of LNDCs has been less well characterized in direct antigen 
capture from the lymph, at least one subset (CD11bhi CD11chi CD8a- SIGNR-1hi) have been 
shown to be directly involved in antigen capture and the ensuing humoral response in the case 
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dendritic cell acquisition and priming within the medulla as an important pathway in driving 
downstream adaptive immunity. 
  In light of these four mechanisms, the initiation of adaptive immunity in the LN can be 
viewed as series of steps whereby lymph flow carries antigen from its source in the periphery 
towards the draining LN, and independent populations of innate immune cells attempt to utilize it 
effectively throughout that journey. Especially in the case of vaccination, the high concentration 
of injected antigen ensures passive antigen delivery to the draining LN, and the engagement of 
antigen presentation mechanisms beyond traditional transport by migratory DCs. As a result, it 
may be critical to understand the influence that these pathways have in governing adaptive 
response to vaccination, and the underlying LN environment which serves as their context. This 
study attempts address some of these questions in the following steps: 
1. Utilize novel imaging tools to clarify the collagen networking within the LN, which may 
play a critical role in lymph flow and immune response 
 2. Understand the role of the LN stroma, specifically fibroblastic reticular cells, in 
maintenance of both homeostatic and inflammatory immune function 
3. Identify novel mechanisms by which LNDCs utilize LN architecture to optimize antigen 

















Chapter 2      
B cell homeostasis and follicle conﬁnes are governed 
by ﬁbroblastic reticular cells         
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 18Chapter 2.1 – Introduction 
   
  Secondary lymphoid organs are essential sites for the induction of adaptive immune 
responses. One of their most remarkable features is the segregation of B and T cells into 
discrete domains comprising structural and functional units for optimal immune cell 
activation(Turley et al., 2010; Mueller and Germain, 2010). These specialized environments are 
inhabited by different subsets of mesenchymal stromal cells, which are commonly viewed as 
serving scaffolding function for T and B lymphocytes and dendritic cells. Current dogma holds 
that fibroblastic reticular cells (FRCs) within the paracortical region coordinate T cell responses 
whereas follicular dendritic cells (FDCs) within the cortex support B cell responses. However, a 
precise understanding of how the stromal network of lymphoid organs controls adaptive 
immunity has been beyond our reach due to limitations in the technology for targeting each of 
the mesenchymal cell populations.  
  The T cell paracortical region of the lymph node is delineated by FRCs, the most 
abundant population of non-hematopoietic or stromal cells in this organ. Typified by expression 
of the glycoprotein podoplanin (PDPN), and molecules such as CD140α and CD140β, FRCs 
construct an elaborate conduit network that allows small molecules to rapidly flow from 
upstream tissues deep into the parenchyma of lymph nodes(Gretz et al., 2000; Roozendaal et 
al., 2009; Sixt et al., 2005). Expression of CCL19 and CCL21 by FRCs, in addition to other 
adhesion molecules, facilitates chemokine receptor CCR7-dependent homing of naive T cells 
and provides essential guidance cues to dendritic cells that migrate from non-lymphoid tissues 
into the lymph node paracortex(Acton et al., 2012; Jillian L Astarita, 2012; Malhotra et al., 
2012b). Additionally, interleukin 7 (IL-7) production by FRCs is thought to be essential for 
preservation of the peripheral T cell pool under homeostatic conditions(Link et al., 2007). More 
recently, FRCs have also been found to control the extent of proliferation of newly activated T 
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Siegert et al., 2011).  
  The two stromal cell populations commonly characterized within the lymph node cortex 
include FDCs and marginal reticular cells (MRCs). FDCs are characterized by localization within 
B cell follicles, expression of the complement receptors CR1 and CR2 (CD35 and CD21), the 
follicular dendritic cell marker 1 (FDCM1), and the ability to display opsonized antigens to B 
cells. Expression of B cell trophic factors, namely the chemokine CXCL13 and the pro-survival 
factor BAFF (also known as BlyS, TALL-1, TNFSF13B, TNFSF20), is often attributed to FDCs, 
implicating these cells in shepherding B cells to follicles, supporting B cell survival and 
coordinating the germinal center reaction(Cyster, 2010; Cyster et al., 2003; Roozendaal and 
Carroll, 2007; Tew et al., 1990). Previous work employing a system to ablate FDCs provided 
definitive evidence that, while this stromal subset is critical for germinal center responses, it 
plays only a minor role in B cell homeostasis within resting lymph nodes(Wang et al., 2011). 
Likewise, loss of FDCs was not mirrored by a decrease in Tnfsf13b, hereafter referred to as 
Baff, transcript abundance, pointing to the presence of an alternative source. These 
observations have led some investigators to postulate that MRCs, which reside in close 
juxtaposition to the subcapsular sinus (SCS) of lymph nodes(Katakai et al., 2008), serve these 
functions, but data supporting this hypothesis are not yet available. Thus, the cell population 
supporting B cell homeostasis within primary follicles has remained enigmatic. 
We have developed and experimentally validated an inducible mouse model (Ccl19-Cre x 
Rosa26-diphtheria toxin receptor (iDTR) mice) for conditional ablation of FRCs in vivo. In these 
mice, administration of diphtheria toxin (DTxn) caused a rapid and extensive depletion of FRCs, 
while sparing other stromal cell populations. Our data demonstrate that FRC ablation led to 
marked alterations in T cell homeostasis and compartmentalization, with profound 
consequences in the activation, expansion and effector function of viral antigen-specific T 
lymphocytes. Unexpectedly, loss of FRCs also led to significantly reduced B cell viability and 
altered follicular organization, followed by marked impairment in humoral immunity to T-
 20dependent and T-independent viral antigens. Mechanistically, we determined that a subset of 
FRCs residing within lymphoid follicles establishes a favorable niche for B lymphocytes via 
production of BAFF.  Collectively, these results demonstrate that FRCs are required for the 
generation of virus-specific T cell responses within lymphoid organs. Additionally, our study 
broadens the current paradigm of FRCs solely supporting T cell immunity, and highlights an 
essential role for FRCs in directly controlling B cell homeostasis, distribution and activation. 
 
Chapter 2.2 – In vivo genetic targeting and selective ablation of FRCs     
  Manipulation of FRCs in vivo has been thus far limited by a lack of specific genetic 
models targeting this population of stromal cells. A transgenic Cre mouse line that permits 
targeting of FRCs, in which expression of Cre recombinase is directed by the Ccl19 
promoter(Chai et al., 2013), was only recently generated. By crossing the transgenic Ccl19-Cre 
line to Rosa26-enhnaced yellow fluorescent protein (EYFP) mice, we have generated Ccl19-Cre 
x Rosa26-EYFP reporter mice, in which EYFP expression is achieved following Cre-mediated 
excision of a loxP-flanked transcriptional "stop" sequence (Fig. 5a). Confocal laser scanning 
microscopy of lymph nodes from Ccl19-Cre x Rosa26-EYFP mice revealed expression of the 
transgene in the T cell zone, thereby supporting efficient excision of floxed loci in the expected 
location (Fig. 6a,b).  
  Flow cytometric analysis demonstrated EYFP expression in FRCs, identified as non-
hematopoietic cells expressing the glycoprotein podoplanin (PDPN) and negative for the 
endothelial marker CD31 and the cell adhesion molecule MadCAM-1 (CD45–PDPN+CD31–
MadCAM–) (Fig. 6c and Fig. 5b). EYFP expression was not detected in other lymph node 
stromal cells including lymphatic endothelial cells (LECs, CD45–PDPN+CD31+), blood 
endothelial cells (BECs, CD45–PDPN–CD31+) or integrin α7-expressing pericytes (IAPs, CD45–
PDPN–CD31–) (Fig. 6c), thereby confirming specificity of the Ccl19 promoter. Despite the recent 
 21reports suggesting a close developmental relationship between FRCs and MRCs(Katakai, 
2012) (CD45–PDPN+CD31–MadCAM+), MRCs did not appear to be targeted with Ccl19-directed 
recombinase, as demonstrated by the absence of EYFP expression in MadCAM-1+ cells lining 
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Figure 5. Generation and characterization of Ccl19-Cre x Rosa26-EYFP and Ccl19-Cre x iDTR mice. (a) 
EYFP expression is achieved in Ccl19-Cre x Rosa26-EYFP mice following Cre-mediated excision of a loxP-
flanked transcriptional "stop" sequence.  (b) Representative flow cytometric profile of freshly isolated stromal cells
 from skin draining lymph nodes (n>10 mice from 3 independent experiments). (c) In Ccl19-Cre x iDTR mice, the
 DTxn receptor gene is expressed following Cre-mediated recombination. (d) Confocal analysis of popliteal lymph
 nodes from DTR+Cre+ animals 24 h following DTxn administration stained for IgD, RANK-L and MadCAM. Scale
                                                        (e) Lymph nodes from Ccl19-Cre x iDTR mice were
 collected, lysed in trizol and analyzed for the presence of Rank-l transcript. Lines indicate mean. Data are
                                                                                                              
 from 2-3 separate experiments). NS non significant, * p<0.05the subcapsular sinus expression by flow cytometry and confocal microscopic analysis (Fig. 6c-
e).  
  To generate a mouse model that enables selective depletion of FRCs, mice harboring 
the gene encoding DTR downstream of a floxed transcriptional stop element in the ubiquitously 
expressed Rosa26 locus(Buch et al., 2005) were crossed to Ccl19-Cre mice (Fig. 5c). In these 
mice, cells with an active Ccl19 promoter (FRCs) express the simian DTR, and are selectively 
vulnerable to toxin-induced apoptosis when exposed to DTxn. A single injection of DTxn into 
these mice was sufficient to achieve rapid and extensive ablation of FRCs from lymph nodes. 
FRCs were lost as early as 24 h following DTxn administration (Fig. 7a-c) and deletion was 
specific, as we did not measure changes in cellularity of other lymph node stromal populations, 
including LECs, BECs and IAPs (Fig. 7d). Consistent with FRCs being the predominant source 
 23
Figure 6. Specific Ccl19 promoter activity in FRCs. (a) Popliteal lymph node sections from Ccl19-Cre x 
                                                                                         (b) Figure 
shows higher magnification images of the paracortical area stained for GFP, Desmin and CD4 from mice as in 
                                                             (c) Flow cytometric analysis of freshly isolated 
stromal cells from Ccl19-Cre x Rosa26-EYFP mice showing Ccl19 promoter activity.  FRCs, fibroblastic 
                                                                                                                
                                                                                    (d,e) Confocal micro  
                                                                                                               
                                                                       of the chemokine CCL19 (Malhotra et al., 2012b; Link et al., 2007), its expression in lymph 
nodes was abrogated after FRC ablation, whereas expression of genes shared with other cells, 
such as Ccl21 (Malhotra et al., 2012b), was only partially reduced (Fig. 7e,f). As such, we were 
able to detect MadCAM-1+RANK-L+ cells along the lymph node subcapsular sinus of FRC-
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Figure 7. Conditional ablation of FRCs. (a) The FRC (PDPN+CD31–) compartment was analyzed 24 h after 
DTxn administration in DTR+Cre+ mice that express DTR in Ccl19+ cells, and in DTR+Cre– control mice. 
Numbers shown in quadrants depict percents. (b,c) The effect of DTxn-induced FRC ablation is shown as 
percent among stromal cells (CD45–) and total number per lymph node. Data are representative of at least 
three independent experiments (mean+/-sd, n=4 mice/group per experiment). (d) Ccl19-Cre x iDTR mice were 
injected with DTxn and, 72 h later, lymph nodes were collected, digested and stromal cells enumerated by flow 
cytometry (FRCs, CD45–PDPN+CD31–, LECs, CD45–PDPN+CD31+, BECs, CD45–PDPN–CD31+, IAPs, 
CD45–PDPN–CD31-). Data are representative of at least three independent experiments (mean+/-sd, n=3 
mice/group per experiment). (e,f) Following DTxn administration, lymph nodes were collected, lysed in trizol 
and analyzed for the presence of Ccl19 or Ccl21 transcripts. Lines indicate mean. Data are normalized to 
cyclophillin. Each data point represents one lymph node from an individual mouse (n=4-10 mice/group from 2-3 
separate experiments). (g) MRCs were identified in lymph nodes from Ccl19-Cre x iDTR mice by staining with a 
                                                                                                 
(n>3mice from 3 independent experiments). NSnon significant, *p<0.05, **p<0.01, ***p<0.001ablated mice (Fig. 7g and Fig. 
5d), confirming a lack of Ccl19 
promoter activity in MRCs. In 
line with this finding, Rank-l 
transcript encoded by Tnfsf11, 
which is shared by MRCs and 
FRCs (Malhotra et al., 2012b; 
Katakai et al., 2008), was 
only partially reduced in total 
lymph node mRNA 
preparation after FRC ablation 
(Fig. 5e), despite complete 
abrogation of Ccl19 (Fig. 7e).  
   Despite FRCs 
comprising a minute cellular 
compartment (~0.5% of total 
lymph node cells) (Fletcher et al., 2011), their ablation resulted in marked alterations in lymph 
nodes, with significant reductions in organ size, weight and cellularity (Fig. 8a,b and data not 
shown). However, these effects were not symptomatic of a global collapse of lymph node 
architecture, as FRC ablation perturbed neither the integrity nor the permeability of the conduit 
network (Fig. 8c). DTxn administration was not associated with systemic toxicity, and it did not 
lead to weight loss or extra-nodal pathology (Fig. 9a and data not shown). Furthermore, we did 
not observe accumulation of either neutrophils (CD11b+Gr1hi) or monocytes (CD11b+Gr1neg/lo), 
or increased expression of inflammatory cytokines, ruling out extraneous inflammation 
secondary to FRC ablation (Fig. 9b,c). Collectively, these data suggest that the Ccl19-Cre 
mouse system allows for specific ablation of FRCs in vivo.  
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Figure 8. FRC ablation has profound consequences on lymph node 
cellularity despite preserving conduit functionality. (a,b) Lymph 
node mass and total cellularity after DTxn administration were deter-
mined. Data are representative of at least two independent experiments 
(mean+/-sd, n=3 mice/group per experiment). (c) Representative 
multiphoton microscopic images of popliteal nodes from Ccl19-Cre x 
iDTR mice depicting FITC-tracer transported into conduits. Scale bars 
                                                            
Chapter 2.3 – Ablation of FRCs impairs anti-viral T cell responses 
 
  Confocal laser scanning microscopy of DTxn-treated mice confirmed disappearance of 
FRCs from the T cell zone parenchyma, and revealed aberrant localization of T lymphocytes 
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Figure 9. DTxn injection does not result in systemic toxicity or inflammation. (a) Animal weight was 
determined following DTxn administration (n=3-4 mice/group per experiment from two independent experiments). 
(b) Lymph nodes from Ccl19-Cre x iDTR mice were collected and processed into single cell suspensions. 
Neutrophils (CD45+CD11b+Gr1high), monocytes (CD45+CD11b+Gr1–/low) and dendritic cells 
(CD45+CD11c+MHCII+) were enumerated using flow cytometric analysis. Data are representative of at least 
three independent experiments (mean+/-sd, n=3 mice/group per experiment). (c) Lymph nodes from Ccl19-Cre x 
iDTR mice were collected, lysed in trizol and analyzed for expression of inflammatory mediator genes. Lines 
indicate mean. Data are normalized to cyclophillin. Each data point represents one lymph node from individual 
mice (n=4-10 mice/group from 2-3 separate experiments). NS non significant, *p<0.05, **p<0.01, ***p<0.001within cortical regions (Fig. 10a). Notably, we also observed a global reduction of T cell numbers 
in lymph nodes (Fig. 10b) with both CD4+ and CD8+ T cells equally affected by loss of FRCs 
(Fig. 11a,b). Moreover, expression of the T cell survival factor Il-7 was also reduced in lymph 
 27
Figure 10. FRC ablation impairs T cell immunity. (a) Confocal microscopy of lymph node sections from 
Ccl19-Cre x iDTR mice stained for CD4 (T cells) and PDPN (FRCs) to depict FRCs in paracortical areas 3 days 
                                                                                                            
(b)                                                                                                        
                                                                                                       -
                                                  (c)                                             
                                                                                                                 -
                                                                                                             
2-3 separate experiments). (d,e)                                                                     -
                                                                                                           
                                                                                                                
                                                                                    (f)                
                                                                                               (g,h) Prolifer-
                                                                                                 (i) DTxn-treated
                                                                                                                  -
                                                                                                             
                             (j)                                                                           
                             nodes from FRC-ablated mice, suggesting that diminished T cell viability may compound the 
reduction in T cell numbers (Fig. 10c).  
  To assess the impact of FRC ablation in adaptive T cell responses, Ccl19-Cre x iDTR 
mice were immunized with a replication-incompetent influenza A virus expressing the OT-II 
ovalbumen peptide, and the generation of antigen-specific T effector cells was monitored (Fig. 
11c,d). Loss of FRCs resulted in diminished priming of antigen-specific T cells (Fig. 10d,e), as 
well as reduced activation and proliferation (Fig. 10f-h). Furthermore, deterioration of anti-viral T 
cell responses was observed in a coronavirus-based vector system(Perez-Shibayama et al., 
2013), in which generation and effector function of exogenously transferred TCR transgenic 
CD8+ T cells specific for the viral spike protein prior to immunization (Fig 11e) was monitored. 
Strikingly, generation of the virus-specific T cell response was also profoundly disrupted with 
reduced numbers of antigen-specific CD8+ T cells and defective interferon-γ production in FRC-
ablated mice (Fig. 10i,j). Altogether, our data demonstrate a critical role for FRCs in T cell 
homeostasis, positioning and activation.  
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Figure 11. Effects of FRC ablation on T and B cells. (a,b) Lymph nodes from Ccl19-Cre x iDTR mice were 
collected and processed into single cell suspensions. CD4+ and CD8+ T cells were enumerated using flow 
cytometric analysis (CD45+B220–CD3+CD4+/–CD8+/–). Data are representative of at least three independent 
experiments (mean+/-sd, n=4 mice/group per experiment). (c-e) Schematic representation of the experimental 
protocols utilized to assess T cell immunity. (f) Ccl19 promoter activity was evaluated in B cells from Ccl19-Cre x 
Rosa26-EYFP mice. (g) B cells from DTR+Cre+ mice were cultured in vitro in the presence of DTxn and viability 
was determined over the course of 72 h (n=3 wells/group). NS non significant, * p<0.01, **p<0.001 
Chapter 2.4 – FRC ablation is detrimental to B cells 
 
  Unexpectedly, a substantial reduction in lymph node B cells was identified following 
DTxn administration (Fig. 12a,b). Structural alterations in the lymph node cortex were also 
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Figure 12. FRC ablation is detrimental to B cells. (a,b) Skin-draining lymph nodes from 
Ccl19-Cre x iDTR mice were collected, processed into a single cell suspension and B cells 
numbers were determined by flow cytometric analysis (CD45+B220+CD3–). B cell numbers are 
shown as percent among hematopoietic (CD45+) cells and total numbers per lymph node. Data 
are representative of at least three independent experiments (mean+/-sd, n=4 mice/group per 
experiment). (c,d) Follicle size (n=3mice) and architecture (n>3mice from 3 independent 
experiments) in lymph node sections from Ccl19-Cre x iDTR mice was determined 3 days after 
                                                                                     (e) 
Popliteal nodes were collected 14 days after influenza immunization and analyzed for the 
presence of germinal centers. (B220, B cells; GL7, activated B cells; CD35, FDCs. Scale bars 
        (f) T-independent (IgM) and T-dependent (IgG2b) humoral responses were determined 
by ELISA for the presence of flu-specific serum antibodies. Data are representative of two 
independent experiments (n=3-5 mice/group per experiment). *p<0.05, **p<0.01, ***p<0.001observed, with reduced follicle size (Fig. 12c) and a loss of follicle boundaries (Fig. 12d). 
Ultimately, this resulted in an unfurling of the B cell zone with mixing of B and T lymphocytes 
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Figure 13. FRC ablation disrupts splenic white pulp organization and marginal zone humoral responses. 
(a) Confocal analysis of spleen sections from Ccl19-Cre x Rosa26-EYFP mice stained for GFP, B220 and CD4. 
                                                                                     (b-e) Spleens from 
                                                                                                  
                                                        (f,g)                                              
                                                                                                            -
                                     (h)                                                                      
                                                                                                    (i) B cells
                                                                                                             
                                                                                 (j)                            
                                                                                                        
                . (k)                                                                                  
                                                                                             throughout the cortex (Fig. 12d). Notably, no Ccl19 promoter activity or intrinsic toxicity of DTxn 
in B lymphocytes was detected, suggesting a physiologic relationship between B cell 
homeostasis and the presence of FRCs (Fig. 11f,g). 
To determine the functional consequences of the aberrant follicular architecture and decreased 
B cell numbers, the ability of FRC-ablated mice to mount a humoral response to influenza A 
virus was assessed. Immunization with UV-inactivated influenza virus resulted in a disorganized 
accumulation of B cells in the ensuing germinal center response (Fig. 12e), as well as a 
significant reduction in influenza-specific IgM (T-independent(Gonzalez et al., 2010)) and IgG2b 
(T-dependent) antibody production (Fig. 12f).  
  The detrimental effect of FRC ablation on B cells was not restricted to lymph nodes. In 
splenic white pulp, where the Ccl19 promoter is active in both FRCs and CD31–PDPN– (DN) 
cells ((Chai et al., 2013) and Fig. 13a), DTxn administration efficiently targeted EYFP+ stroma 
(Fig. 13b,c), with a significant decrease in FRCs and DN cells (Fig. 13d,e). FRC ablation had 
no effect on splenic weight or cellularity (Fig. 13f,g) but markedly altered white pulp architecture 
(Fig. 13h). B cell numbers were also reduced in the spleen (Fig. 13i), although to a lesser 
extent than in lymph nodes (Fig. 13j). Functionally, the effects observed in the spleen impinged 
on marginal zone humoral responses, with a significant decrease in IgM production upon TNP-
ficoll immunization (Fig. 13k).  
  As Ccl19 promoter activity was also reported in Peyer’s patches (Fig. 14a), we 
investigated the fate of Peyer’s patches following FRC ablation. Systemic DTxn administration 
evoked less severe effects in Peyer’s patches, with milder reductions in FRC and B cell 
numbers (Fig. 14b,c). Similarly, no major anatomical alterations were observed, with the 
exception of a paucity of T cell clusters in interfollicular regions (Fig. 14d). Together, these 
observations pointed to an unanticipated regulation of B cell homeostasis by FRCs, and suggest 
that damage to the FRC network has deleterious consequences on the cellular circuitries that 
underpin humoral responses.  
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Chapter 2.5 – Lymph node FRCs support homing and survival of B cells 
 
  Given the reported role for FRCs in regulating immune cell trafficking(Acton et al., 2012; 
Jillian L Astarita, 2012; Link et al., 2007; Chyou et al., 2008), we hypothesized that the 
decrease in B cell numbers after FRC ablation could stem from impaired lymphocyte homing to 
 32
Figure 14. Peyer’s patches are only marginally affected by FRC ablation. (a) Confocal analysis of Peyer’s 
                                                                                                      
(n=3 mice from two independent experiments). (b,c) Peyer’s patches from Ccl19-Cre x iDTR mice were 
processed into single cell suspensions and stromal and B cells were enumerated using flow cytometry 72 h after 
DTxn administration. The figure shows two combined experiments (mean+/-sd, n=3 mice/group per experiment). 
(d) Confocal analysis of Peyer’s patches from Ccl19-Cre x iDTR animals 72 h following DTxn administration. 
                                                                                          lymph nodes. To test this hypothesis, congenic CFSE-labeled B cells were adoptively 
transferred into DTxn-treated Ccl19-Cre x iDTR mice, and enumerated within lymph nodes 90 
min and 24 h later by flow cytometry. Donor B cell numbers were markedly reduced in lymph 
nodes of FRC-ablated mice at both time points (Fig. 15a). B cell homing to lymph nodes 
depends on CCL19 and CXCL12 (Okada et al., 2002)), and Cxcl12 expression in FRCs has 
been previously documented(Malhotra et al., 2012b). Indeed, Cxcl12 expression was 
significantly reduced in FRC-ablated mice (Fig. 15b), and FRCs were sufficient to evoke B cell 
chemotaxis in vitro (Fig. 15c), suggesting that FRCs recruit B cells, possibly via CXCL12 and 
CCL19. Importantly, blockade of lymphocyte ingress (via treatment with a CD62L blocking 
antibody) was not sufficient to significantly perturb B cell numbers in the first 24 h after 
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Figure 15. FRCs promotes B cell migration. (a) Ccl19-Cre x iDTR mice were injected with CFSE-labeled, 
CD45.1+ congenic B cells 24 h after DTxn administration. Homing of B cells to lymph nodes was evaluated 90 
min or 24 h later. Data are representative of three independent experiments (mean+/-sd, n=3 mice/group per 
experiment). (b) Lymph nodes from Ccl19-Cre x iDTR mice were collected, lysed in trizol and analyzed for the 
presence of Cxcl12 transcript. Lines indicate mean. Data are normalized to cyclophillin. Each data point repre-
sents one lymph node from individual mice (n=4-10 mice/group from 2-3 separate experiments). (c) Purified 
FRCs were cultured in a 24 well plate. CFSE-labeled B cells were seeded on top of a transwell insert and allowed 
to migrate towards the FRCs for 2 h. After that time, cells were recovered and B cells enumerated by flow 
cytometry. The figure shows three combined experiments (mean+/-sd, n= 3 wells/condition per experiment). (d) 
WT mice received one single dose of CD62L-specific antibody i.p. and B cell numbers were determined in lymph 
nodes at different time points. The figure shows two combined experiments (mean+/-sd, n=3 mice/group per 
experiment). (e) Ccl19-Cre x iDTR mice were injected with 1 mg/kg FTY720 i.p. and, 4 h later, with DTxn. B cell 
numbers were determined 24 or 72 h after DTxn administration. For analysis at 72 h, mice received an additional 
dose of FTY720. The figure shows two combined experiments (mean+/- sd, n= 3-4 mice/group per experiment). 
NS non significant, *p<0.05, **p<0.01, ***p<0.001treatment (Fig. 15d), in contrast to the rapid B cell loss observed in FRC-ablated mice (Fig. 
12a,b). Additionally, preventing lymphocyte egress from lymph nodes with a sphingosine 1-
phosphate receptor antagonist, FTY720, did not completely restore B cell numbers following 
FRC ablation (Fig. 15e).  
  Altogether, these data suggest that while B cell entry requires an intact FRC network, 
impaired B cell trafficking can only account for part of the reduction in B cell numbers following 
FRC ablation. This consideration prompted investigation of the possibility that FRCs may 
regulate additional aspects of B cell homeostasis. Consistent with this hypothesis, B cell loss in 
FRC-ablated mice coincided with a significant increase in propidium iodide-positive B cells (Fig. 






                                 






   
 35
Figure 16. FRC ablation impairs B cell survival. (a,b) B cell viability was assessed by flow cytometric 
analysis of lymph node single cell suspensions (CD45+B220+PI+).  Representative dot plots of PI+ stain in B 
cells at 72 h are depicted. Data are representative of two independent experiments (n=3-5 mice/group per 
experiment). (c) Confocal images of lymph nodes from Ccl19-Cre x Rosa26-EYFP mice to depict FRCs in 
                                                                                                            
independent experiments). (d) Confocal analysis of popliteal lymph nodes from Ccl19-Cre x Rosa26-EYFP 
reporter mice stained for FDCM1, CXCL13, GFP and CCL21. Left, chemokine expression is shown; middle, 
                                                                                                                
independent experiments). (e) Confocal analysis of popliteal lymph nodes from Ccl19-Cre x iDTR animals 24, 
                                                                                                             
group). (f) Quantitation of cumulative FDCM1 expression within the follicles of images as in (e). Each point 
represents a single lymph node from an individual mouse. (g,h) Changes in Baff expression and B cell numbers 
were compared between FRC-ablated mice (Ccl19-Cre x iDTR) and FDC-ablated mice (Cd21-Cre x iDTR, 
lethally irradiated and reconstituted with WT bone marrow) 24 h after DTxn administration (n=2-4 mice/group). 
(i,j) Three days after DTxn administration, lymph nodes from Ccl19-Cre x iDTR were collected, lysed in trizol 
and analyzed for the presence of Baff and April transcripts. Lines indicate mean. Data are normalized to 
cyclophillin. Each data point represents one lymph node from individual mice (n=6-8 mice/group from 3 
separate experiments). (k) BAFF protein production in FRC-ablated mice was determined by confocal micros-
copy in lymph nodes from Ccl19-Cre x iDTR stained with an antibody against BAFF together with DAPI. Scale 
                                                                                                       
 
 36
Fig 16, continuedChapter 2.6 – FRC ablation impairs BAFF production in vivo 
 
  Most efforts to characterize FRCs have thus far focused on their roles in supporting T 
cell homeostasis, migration and activation. However, a discrete population of FRCs is also 
found in and around follicles (B cell zone FRCs, Fig. 16c), and it was reasoned that such a 
locale could position FRCs to directly interact with and influence B cells. This observation, 
together with the decreased B cell survival observed in FRC-ablated mice, led to the hypothesis 
that FRCs may provide critical survival factors for naive B cells. In this context, BAFF plays a 
critical role in survival of mature B cells(Mackay and Browning, 2002; Gorelik et al., 2003). The 
key source of BAFF in secondary lymphoid organs was previously identified as a radiation 
resistant cell(Gorelik et al., 2003), with FDCs often considered the sole BAFF-producing 
stromal cell(Garin et al., 2010). Thus, it was possible that the phenotypes observed in FRC-
ablated mice may be secondary to a reduction in FDCs.  
  To test if FDCs were directly targeted in our system, we ascertained whether the Ccl19 
promoter was active in follicular dendritic cells (FDCs) in situ by fluorescence imaging in Ccl19-
Cre x Rosa26-EYFP mice. As depicted by FDCM1 and CXCL13 staining, EYFP was absent in 
the majority of FDCs in steady state lymph nodes (Fig. 16d). Less EYFP staining was detected 
in a small number of FDCM1+ processes (Fig. 16d), possibly due to the tight interconnections 
that exist between FRCs and FDCs in follicles(Roozendaal et al., 2009; Gonzalez et al., 2011). 
Additionally, to assess the status of FDCs in FRC-ablated mice, we performed quantitative 
microscopic analysis of lymph nodes at different time points after DTxn administration. Our data 
demonstrated that FDCs are present 24 h after DTxn administration (Fig. 6e and quantified in 
Fig. 16f), despite profound loss of FRCs (Fig. 2c). Furthermore, FDCs remained functionally 
competent at this time point, as demonstrated by their ability to correctly display exogenous 
immune complexes (Fig. 17a). Prolonged DTxn exposure led to a progressive reduction in FDC 
volume, as depicted by a decrease in FDCM1 integrated intensity (Fig. 16e,f) and decreased 
CD35 staining as well (data not shown). Notably, contraction of the FDC network appeared to 
be transient and was followed by reappearance of FDCM1+ cells 3 days after FRC ablation (Fig. 
 3716e,f). Furthermore, direct comparison of FRC and FDC ablation revealed that loss of FRCs 
rapidly abrogated Baff expression in vivo while depletion of FDCs did not (Fig. 16g).  
  Together these results point to a previously unrecognized regulatory role for FRCs in 
maintaining BAFF amounts and B cell viability. Accordingly, the large decrease in B cell 
numbers was only observed in FRC-ablated mice but not in FDC-ablated animals (Fig. 16h). 
Notably, FRC ablation perturbed Baff expression without perturbing expression of the closely 
related factor April encoded by Tnfsf13 (Fig. 16i,j). Moreover, impaired Baff mRNA expression 
in FRC-ablated mice was mirrored by a similar abrogation in BAFF protein abundance, as 
assessed by confocal microscopic analysis of lymph node sections (Fig. 16k). Interestingly, 
concentrations of BAFF protein in serum were unperturbed in FRC-ablated mice (Fig. 17b), 
indicating that FRC loss influences local BAFF production rather than perturbing a systemic 
reservoir. Furthermore, by injecting carefully titrated DTxn in the footpad, we were able to 
achieve anatomically restricted FRC ablation, and consequently B cell loss, only in the draining 
popliteal lymph nodes, without disrupting distal lymph nodes (Fig. 17c,d). Thus, the functional 
consequences of FRC depletion on B cell homeostasis are primarily mediated by a local effect 




Chapter 2.7 – B cell zone FRCs constitute a chief source of BAFF 
 
  The data shown so far suggest that FRCs may directly promote B cell survival by serving 
as a non-redundant source of BAFF, in agreement with previous studies demonstrating Baff 
mRNA expression in highly purified FRCs(Malhotra et al., 2012b). Confocal microscopic in situ 
analysis of B cell zone FRCs revealed that these cells are indeed capable of producing BAFF 
protein (Fig. 18a). In line with this finding, BAFF production was also observed by flow 
cytometry in a discrete fraction of freshly isolated FRCs (Fig. 18b). Notably, BAFF was rapidly 
 38cleaved from the cell surface in a protease-dependent manner, similar to other molecules 
belonging to the TNF superfamily (Fig. 17e). Importantly, BAFF+ cells were characterized by 
expression of several FRC canonical genes encoding PDPN, α-smooth muscle actin (αSMA), 
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Figure 17. Functional consequences of FRC-ablation. (a) Ccl19-Cre x iDTR mice were injected with DTxn, 
followed by passive immunization with rabbit anti-phycoerythrin. 18 h later, mice received phycoerythrin (PE) in 
the footpad and the popliteal node was imaged 6 h later for B220, FDCM1 and PE. (n=3 mice). (b) Serum was 
collected from Ccl19-Cre x iDTR mice 3 days after DTxn administration and levels of circulating BAFF were 
determined by flow cytometry-based bead assay. Each dot represents a mouse. (c,d)  Ccl19-Cre x iDTR mice 
were injected in the footpad with 0.5 ng/g DTxn and numbers of FRCs and B cells were determined by flow 
cytometry 72 h later. Data are representative of two independent experiments (mean+/-sd, n=3 mice/group per 
experiment). (e) After enzymatic digestion of lymph nodes, cell suspensions were left untreated in complete 
medium or treated with protease inhibitors at room temperature. BAFF staining was evaluated by flow cytom-
etry at different time points. Data are representative of three independent experiments. (f) CFSE-labeled 
purified B cells were cultured in vitro for 5 days in contact with FRCs, separated from FRCs by a transwell filter 
(TW), or with FRC-conditioned culture supernatant. B cell proliferation was determined as CFSE dilution in 
B220+ cells. NS non significant, * p<0.001 40
Figure 18. FRCs support the survival of B cells through the production of BAFF. (a) BAFF 
production by FRCs (EYFP+ cells) was determined in Ccl19-Cre x Rosa26-EYFP mice by staining 
lymph nodes with a BAFF-specific antibody together with anti-GFP and DAPI. Line depicts lymph node 
                                                                                                  
experiments). (b)                                                                          
                                                                                                       
separate experiments). (c) Flow cytometric  analysis of canonical FRC marker expression in BAFF+ or 
BAFF– FRCs. (d) Purified B cells were cultured alone or in the presence of FRCs and cell viability was 
determined daily by enumerating the numbers of PI–B220+ cells in each well. Data represent three 
                                                                        (e) B cell viability was 
determined at day 5 in B cells cultured alone, in contact with FRCs, separated from FRCs by a transwell 
filter (TW), or with FRC-conditioned culture supernatant (FRC sup). Data represent three independent 
                                                      (f) B cells were cultured alone or with FRC-
conditioned supernatant (FRC sup). BAFF-specific neutralizing antibody was added to some of the wells 
 and B cell viability was determined by flow cytometry. Data represent three independent experiments
                                                    CD44, Cadherin-11, CD140α and CD140β, VCAM, and fibroblast-activation protein (FAP)  (Fig. 
18c), supporting that these cells are nearly identical to FRCs. Thus, our data suggest that FRCs 
positioned in follicular regions contribute to B cell homeostasis by providing the pro-survival 
factor BAFF.  
  To directly test the aforementioned hypothesis, we cultured B cells in the presence or 
absence of FRCs and measured B cell viability using propidium iodide staining by flow 
cytometry. Remarkably, B cells exhibited significantly enhanced viability when cultured in the 
presence of FRCs compared with B cells cultured alone (Fig. 18d). The elevated number of 
propidium iodide-negative B220+ cells in cultures with FRCs could not be accounted for by 
proliferation (Fig. 17f). To ascertain whether the survival advantage conferred by FRCs was due 
to a soluble factor, B cells were cultured with stromal cells in separate compartments of a 
transwell chamber or with FRC-conditioned medium. In both conditions, B cells exhibited 
enhanced viability indicating the presence of a soluble pro-survival factor derived from FRCs 
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Figure 19. FRC model. Juxtaposed to marginal reticular cells (MRCs) underneath the subcapsular 
sinus and at the boundary between T and B cell zones, FRCs nurture B cells by producing BAFF. 
Ablation of FRCs has detrimental effects on B cell homeostasis: the architectural integrity of primary 
follicles is lost and B cell viability is profoundly decreased, leading to a significant loss of B lympho-
cytes.(Fig. 18e). Next we sought to determine whether the pro-survival factor contributed by FRCs 
was BAFF. To this end, FRC-conditioned medium was pre-incubated with a BAFF-specific 
blocking antibody prior to addition to B cells. Strikingly, the enhancement of B cell survival was 
largely abrogated following BAFF neutralization (Fig. 18f). In sum, our data describe a subset of 
FRCs delineating the borders of B cell follicles in lymph nodes (B cell zone FRCs) that nurture B 




Chapter 2.8 – Discussion  
   
  The absence of genetic tools for targeting FRCs has limited systematic, in vivo 
assessment of their precise function in lymphoid organs. Recent generation of Ccl19-Cre mice 
provided a solution to this technological limitation. In particular, DTR cell  type--specific 
expression of DTR allowed us to test the functional outcomes of disrupting the FRC network in 
physiological settings. FRC ablation caused a severe reduction in T cell numbers in resting 
lymph nodes, and marked impairment in antigen-specific T cell responses. Unexpectedly, FRC 
ablation was not immediately accompanied by a collapse of the structured conduit system, 
suggesting that lymph node infrastructure can persist and function for longer periods following 
damage to stromal cells. Rather, the absence of the cellular source of the reticular network (that 
is, the FRCs) impinged on T cell dynamics and function. Thus, our study demonstrates that 
FRCs are essential for optimal T cell immunity but not short-term maintenance of the conduit 
system. 
  Using this genetic approach we made the unexpected observation that FRCs direct B 
cell homeostasis. While most lymph node FRCs reside within the T cell-rich paracortex, some 
localize in the vicinity of follicular conduits near the subcapsular sinus (Roozendaal et al., 2009; 
Gonzalez et al., 2011). Our identification of Ccl19-Cre+ cells in B cell follicles (B cell zone 
 42FRCs) confirmed that FRCs span both the inner and outer regions of the lymph node (Bajénoff 
and Germain, 2009). Unexpectedly, we found that B cell zone FRCs constitute a non-redundant 
source of BAFF. The source of BAFF in secondary lymphoid organs was previously identified as 
a radio-resistant cell (Gorelik et al., 2003), often attributed to FDCs. This concept was 
confounded however by reports that abrogation of LTβR signaling, critical for FDC development 
and maintenance, did not affect BAFF expression or B cell numbers(Alimzhanov et al., 1997; 
Boulianne et al., 2013; Browning et al., 2005; Koni et al., 1997). Further, Cd21-Cre conditional 
ablation systems provided evidence that FDCs are dispensable for BAFF expression and naive 
B cell survival(Wang et al., 2011). Although it cannot be excluded that FDCs contribute to BAFF 
production and their ablation induces a compensatory up-regulation by other cells, these data 
pointed to an alternate source of BAFF in resting lymph nodes. Based on our data, we propose 
that B cell zone FRCs represent this source of BAFF and thereby directly support B cell 
homeostasis. Disrupted follicular organization in FRC-ablated mice may also contribute to 
decreased B cell survival, as FRCs in intact lymphoid organs would coordinate migration of 
naive B cells from high endothelial venules to BAFF-rich follicles.  
  As a functional consequence of impaired B cell homeostasis in Ccl19-Cre x iDTR mice, 
generation of humoral responses was severely compromised. We cannot exclude that FRC 
ablation affects the ability of dendritic cells to capture and deliver antigens, thus contributing to 
the diminished antibody production observed following FRC loss. However, our findings indicate 
that alterations in lymph node stromal composition can have catastrophic consequences on 
immunological competency, with decreased lymphocyte viability and disorganized spatial 
coordination of T and B cell responses.  
  Having demonstrated a central role for FRCs in B cell homeostasis and humoral 
immunity, our findings highlight the pleiotropic nature of FRCs and indicate functional 
heterogeneity, raising the intriguing concept of distinct FRC subsets within defined lymph node 
regions. In this context, stromal cells are thought to arise from a primordial mesenchyme in the 
lymph node anlagen, which initially develops into lymphoid tissue organizer (LTo) cells(Mebius, 
 432003). B and T lymphocyte colonization after birth then promotes the development of 
conventional stromal subsets. Similar expression patterns of cellular markers between MRCs 
and LTo cells suggested that MRCs may differentiate into FRCs and FDCs and continuously 
supply additional stromal subsets (Katakai et al., 2008). If indeed FRCs arise from MRCs in 
adult lymph nodes, then the Ccl19 promoter must be silenced in MRCs. Furthermore, our 
studies indicated that most FDCs were devoid of promoter activity, and should thus be refractory 
to DTxn-induced apoptosis. A few cell processes from FDCM1+ cells displayed weak positivity 
for EYFP. However, given the tight association between FRCs and FDCs in follicles 
(Roozendaal et al., 2009; Gonzalez et al., 2011), it remains difficult to discern between promoter 
activity in these FDCs, or proximity to EYFP+ FRCs in follicular regions. In this regard, we 
observed functionally competent FDCs early after DTxn administration, when profound loss of 
FRCs has already occurred, suggesting that FDCs are not directly targeted in this system. 
Consequently, reduction of FDCM1 staining at later time points, likely mediated by a contraction 
or de-differentiation of the FDC network , may arise from a yet unrecognized crosstalk between 
FRCs and FDCs. Our finding that contraction of the FDC network was transient and rapidly 
followed by a regeneration phase is of particular interest. One potential explanation is that 
damage to the FDC network, secondary to FRC loss, may induce MRCs to generate new 
FDCM1+ cells(Jarjour et al., 2014).  
As complexity of the cellular constituents of lymph node stroma continues to grow, our 
understanding of their developmental origins and functional interactions remains incompletely 
understood. Our results demonstrate heterogeneity within the FRC network and indicate 
functional specialization of T cell zone FRCs versus B cell zone FRCs. BAFF+ FRCs in follicles 
share common signatures with canonical FRCs, suggesting that there is some relationship 
between them. However, they differ in their localization, and BAFF-producing cells are not found 
in T cell areas. As mesenchymal cells are typically highly flexible in nature depending on the 
surrounding environment it is possible that BAFF production by B cell zone FRCs is maintained 
by microanatomic cues. Several functions associated with T cell immunity have been assigned 
 44to FRCs(Gretz et al., 2000; Roozendaal et al., 2009; Link et al., 2007; Chai et al., 2013; 
Chyou et al., 2008; Yang et al., 2014), yet the requirement for these cells in humoral responses 
has not been addressed. Our finding that B and T cell homeostasis is governed by a common 
stromal cell expands our understanding of the stromal network and underscores its central role 
in immunity.  
  Stromal cells have long been recognized as key structural components of secondary 
lymphoid organs(Junt et al., 2008). More recently, we have come to understand how stromal 
cells interact with hematopoietic cell populations and influence adaptive immunity(Koning and 
Mebius, 2012; Malhotra et al., 2012a). A number of pathogens have been reported to affect the 
stromal network in mammalian lymphoid organs and such alterations can be deleterious to host 
defense and vaccine responsiveness(Scandella et al., 2008; Mueller and Germain, 2010). 
Here, we uncovered the existence of a mesenchymal cell population with FRC characteristics 
that supports follicle identity and B cell survival through localized production of BAFF. We 
anticipate that these findings may inform new approaches to boost natural and vaccine-induced 
humoral immunity and protect against potentially devastating infections. 
Chapter 2.9 – Methods   
Mice.  Ccl19-Cre mice were previously described(Chai et al., 2013). Rosa26-EYFP (stock 
number 006148), Rosa26-DTR (iDTR, stock number 007900) Cd21-Cre (stock number 006368) 
and OT-II (stock number 004194) were purchased from Jackson Laboratory. Mice were 
maintained under specific pathogen-free conditions in accordance with institutional and National 
Institute of Health guidelines and used at 5-7 weeks of age. Experiments were conducted 
without blinding using sex and age matched mice for all in vivo experiments. For multiple time-
point experiments, mice were randomly assigned to each group. Animal studies were approved 
by the Research Animal Care committee of Dana-Farber Cancer Institute. 
 
 45Antibodies. The following antibodies were used: αCD45 (30-F11), αCD31 (390), αPDPN 
(8.1.1), αMadCAM (MECA-367), , αB220 (RA3-6B2), αAlphaSMA (1A4), αThy1 (53-2.1), 
αCD140α (APA5), αCD140b (APB5), αCD106 (429), αCD11b (M1/70), αCD11c (N418), αGr1 
(RB6-8C5), αMHC class II (M5/114.15.2), αCD4 (RM4.5) and αCD8 (RM2206) from Biolegend,  
αBAFF (121808 from R&D), anti-GFP (A10263 from Life Technologies). 
 
Systemic FRC ablation in vivo. Ccl19-Cre mice were bred to Rosa26-iDTR to generate Ccl19-
Cre x iDTR animals. DTR+Cre+ mice that express DTR in Ccl19+ cells and DTR+Cre– control 
mice were injected i.p. with 8 ng/g DTxn and sacrificed at 12, 24, 48 or 72 h as indicated in 
figure legends. Ablation efficiency was assessed by flow cytometry at various time points with 
80–90% reduction in FRCs (CD45–PDPN+CD31–) commonly seen by 72 h. Ccl19-Cre+iDTR+ 
(DTR+Cre+) and Ccl19-Cre–iDTR+ (DTR+Cre–) 
 
Local FRC ablation in vivo. DTR+Cre+ mice that express DTR in Ccl19+ cells and DTR+Cre– 
control mice were injected in the footpad with 0.5 ng/g DTxn and sacrificed 72 h later. Local 
ablation was assessed by comparing FRC ablation in draining (popliteal) and non-draining 
lymph nodes.  
 
FDC ablation in vivo. Cd21-Cre mice were bred to Rosa26-iDTR to generate Cd21-Cre x iDTR 
animals. For FDC ablation experiments, 6 week-old, male recipients were irradiated and 
adoptively transferred with bone marrow from WT C57BL/6 mice. 6 weeks after reconstitution, 
mice were injected i.p. with 8 ng/g DTxn and sacrificed 24 h later.   
 
Anti-viral T cell-dependent responses. Influenza propagation and isolation was carried out as 
previously described(Gonzalez et al., 2010). 3 days after DTxn administration, mice were 
adoptively transferred with 5 × 106 CFSE-labeled, purified OT-II transgenic CD4+T cells by tail 
 46vein. 24 h later, mice received 20 µl virus suspension (1 × 106 p.f.u.) S.C. into the footpad. Mice 
were sacrificed 24 h later and flow cytometric analysis was performed on popliteal lymph nodes. 
Activation and CFSE dilution were determined 60 h after T cell transfer. For the coronavirus 
experiments, DTxn injection was performed 72 h before adoptive T cell transfer23. A total of  2 × 
106 TCR-S transgenic CD8+T cells were transferred by intravenous injection and, 12 h after 
transfer, the mice were subcutaneously injected with 3 × 106 of non-replicating coronaviral 
particles in both flanks23. A second injection of non-replicating coronaviral particles was 
performed 12 h following the first one. Lymph nodes were analyzed 72 h after the first viral 
particle injection. 
 
Anti-viral humoral responses. 2 days after DTxn administration, mice received 20 µl influenza 
virus suspension (1 × 106 p.f.u.) subcutaneously into the footpad. 14 days later, popliteal 
draining lymph nodes were collected, cryopreserved and imaged to determine formation of 
germinal centers. Additionally, serum was collected to determine the presence of influenza-
specific antibodies. ELISA analysis of serum was carried out through immobilization of UV-PR8 
on a high binding plate, addition of collected serum, and probing for specific binding of IgM or 
IgG2b (Sigma) using standard alkaline phosphatase development. For TNP-Ficoll immunization 
experiments, mice were injected with DTxn and, 2 days later, with TNP-ficoll i.p. (250 µg/
mouse). IgM antibody titers were determined at day 8 in the blood.  
 
Anti-CD62L and FTY720 treatments. For CD62L blockade, mice received one single dose of 
MEL-14 CD62L antibody i.p. (200 µg/mouse, BioXcell). To prevent cell egress, mice were 
injected with 1 mg/kg FTY720 Fingolimod, R&D) i.p. and, 4 h later, with DTxn. Mice received an 
additional dose of FTY720 at 48 h and were sacrificed for analysis at 72 h.  
 
 47BAFF Serum. Serum was collected from mice 3 days after DTxn administration and stored at 
-80 °C until processing. Soluble BAFF was measured in the serum samples at a 1:2 dilution 
using a modified cytometric bead array. BD CBA Functional Beads (BD Biosciences) were 
activated and coated with immunopure streptavidin (Thermo Scientific) per manufacturer’s 
instructions. For array development, a commercial anti-BAFF ELISA kit (R&D systems, catalog 
#DY2106-05) was used in an inverted manner. Biotinylated detection antibody was incubated 
with 30 µl of streptavidin-conjugated bead slurry at 3 µg/ml and subsequently washed three 
times with PBS containing 3% FBS. Following overnight blocking, serum samples were 
incubated with anti-BAFF beads in Multiscreen plates (Millipore) for 2 h.  Beads were then 
washed three times with 3% FBS in PBS. ELISA capture antibody was used to detect BAFF 
bound to beads at a concentration of 4 µg/ml.  Following 1 h incubation, beads were washed, 
followed by incubation with goat anti-rat Alexa 546 antibody (Molecular Probes) for 1 h. Beads 
were washed three times with 3% FBS in PBS followed by an additional four washes in PBS 
alone. Fluorescence was detected on a BD FACSAriaIIIu, and data were analyzed using FlowJo 
software. 
 
Enzymatic digestion of lymphoid organs. For flow cytometric analysis or cell culture of lymph 
node stromal cells, skin-draining lymph nodes from individual mice were dissected and 
incubated at 37 °C in RPMI containing 0.1 mg/ml Dnase I (Invitrogen), 0.2 mg/ml Collagenase P 
(Roche) and 0.8 mg/ml Dispase (Roche) for 50–60 min22. Cells were collected in PBS 
containing 2% FBS and 5 mM EDTA every 15–20 min, replacing the digestion medium with new 
one. Digestion of spleens was performed similarly, and red blood cells were lysed with ACK 
buffer before analysis by flow cytometry. Peyer’s patches were collected and washed in 2 mM 
EDTA and 1 mM DTT in PBS to remove the epithelium before enzymatic digestion.   
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FRC culture in vitro. Single cell suspensions from pooled skin-draining lymph nodes were 
enriched for MadCAM-1– cells using a biotinylated MadCAM-1-specific antibody and anti-biotin 
microbeads (Miltenyi). Cells were counted and plated at a density of 5 × 105 cells/cm2 in αMEM 
supplemented with 10% FBS, 1% penicillin/streptomycin and 1% glutamine. Non-adherent cells 
were removed after 24 h. After 5 days, primary cultures (FRCs and LECs primarily) were 
harvested and MACS-purified for CD45–CD31– cells (FRCs).  
 
FRC-B cell cocultures. FRCs were purified from primary lymph node cultures (see above) and 
seeded at a concentration of 2.5 × 105 cells/ml in complete αMEM medium. Freshly purified 
lymph node B cells (B220 negative selection kit, Miltenyi) were overlaid on top of the FRC layer, 
at a ratio of 1 FRC : 5 B cells. In some experiments, FRCs were grown on the bottom of a 
transwell system chamber and B cells were added to the top of the insert. Alternatively, B cells 
were cultured in FRC-conditioned medium (supernatant from purified FRCs collected 5 days 
after seeding).  
 
BAFF flow cytometry and protease inhibition. Lymph nodes were enzymatically digested and 
single cell suspensions were stained in flow cytometry buffer. FRCs were identified as negative 
for staining with propidium iodide and CD45–CD31–PDPN+MadCAM–. ABAFF monoclonal 
antibody or isotype control (both from R&D, BAFF clone 121808) were used. For protease 
inhibition, cells were treated with Batimastat (25 µM in DMSO, abcam) and Decanoyl-Arg-Val-
Lys-Arg-Chloromethylketone (25 µM in DMSO, Bachem). 
 
Immunohistochemistry and confocal microscopy. Isolated tissues were fixed in 4% 
paraformaldhehyde (PFA) for 2–4 h, and placed in 30% sucrose until saturation. Tissue was 
 49embedded in OCT medium (Optimal Cutting Temperature), frozen, and cut into 10–20 µm 
sections. Sections were immunostained, and imaged using a Leica SP5X laser-scanning 
confocal microscope. All of the images with EYFP signal were counterstained with a chicken 
GFP-specific antibody (Life Technologies), followed by FITC-conjugated anti-chicken antibody. 
 
PE immune complexes deposition. PE-IC uptake by FDCs was assessed by standard 
confocal microscopy. 18 h following FRC ablation, mice were passively immunized with 100 µg 
rabbit PE monoclonal antibody, followed 6 h later by S.C. footpad injection of 1 µg PE. Popliteal 
draining lymph nodes were fixed in 4% PFA, cryopreserved, sectioned, and imaged as 
described above. 
 
Conduit analysis. Mice were injected i.v. with 3 µg CD35 (clone 8C12) antibody conjugated to 
alexa-568 6-18 h prior to lymph node harvest. Conduit staining was achieved through s.c. 
injection of FITC-saturated PBS solution (10 µl) into the footpad 4-6 h prior to popliteal lymph 
node harvest.  
 
FDC quantitation. Popliteal lymph nodes from DTxn-treated mice were isolated and fixed in 4% 
PFA. Lymph nodes were equilibrated in 30% sucrose and serially sectioned. 4 sections from 
each individual lymph node were taken at 100 µm increments through the lymph node, and 
stained for confocal microscopic analysis. Resulting images were analyzed using CellProfiler to 
identify individual B cell follicles within each section. Fluorescence data was assessed for each 
follicle, and then integrated such that each lymph node data point represents at least 3 
combined sections.  
 
Statistical analysis. Two-tailed, unpaired student’s t-tests were performed, assuming equal 
sample variance, using GraphPad Prism. Differences were considered to be statistically 
 50significant when P < 0.05. For graphs, data are shown as mean +/- SD, unless otherwise 
indicated. Sample size was not specifically predetermined, but the number of mice used was 
consistent with prior experience with similar experiments 
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Chapter 3      
 Trans-nodal migration of resident DCs into medullary 
inter-follicular regions initiates immunity to inﬂuenza 
vaccine 
       
Text and figures adapted from: 
 
Woodruff, M.C., Heesters, B.A., Herndon, C.N., Groom, J.R., Thomas, P.G., Luster, A.D., Turley, 
S.J., Carroll, M.C. 2014. Trans-nodeal migration of resident dendritic cells into medullary 
interfollicular regions initiates immunity to influenza vaccine. J. Exp. Med. 211 (8) 
1611-1621. doi:10.1084/jem.20132327 
           
     
 52Chapter 3.1 – Introduction 
   
  Since early descriptions of dendritic cells (DCs) as primary stimulators of adaptive 
immunity(Steinman, 1991), their role in establishing and regulating immune responses has been 
central to diverse immunological fields such as transplantation(Larsen et al., 1990; Hill et al., 
2011), autoimmunity(Llanos et al., 2011), infectious disease(Poudrier et al., 2012), and 
vaccinology(Arnason and Avigan, 2012). As critical mediators of antigen presentation, significant 
effort has been spent describing activation of conventional DCs (cDCs) in peripheral 
tissue(Moodycliffe et al., 1994; Austyn, 1996; Rescigno et al., 1997), and characterization of 
their subsequent migration to secondary lymphoid organs(Itano et al., 2003; Randolph et al., 
2005; Alvarez et al., 2008; Tal et al., 2011; Braun et al., 2011). Once in peripheral LNs, migrating 
DC populations (mDCs) from the injection site present antigen to cognate T and B cells and 
stimulate adaptive immunity(Qi et al., 2006). 
  The activation and maturation of mDCs is thought to follow a three-stage process.  First, 
immature DCs encounter antigen in the periphery leading to upregulation of MHC class II and 
costimulatory molecules with a concomitant reduction in phagocytic capacity(Rescigno et al., 
1997). Second, antigen loaded DCs acquire migratory capacity through the expression of matrix 
metalloproteases(Yen et al., 2008), migratory adhesion molecules(Acton et al., 2012), and rapid 
actin treadmilling in order to enter and migrate along lymphatic vessels(Lämmermann et al., 
2008). Finally, lymph node (LN) bound mDCs cross the subcapsular sinus floor into the 
paracortical region and interact with cognate T cells and lymph node resident DCs (LNDCs) 
within the draining LN (Braun et al., 2011; Allan et al., 2006) to establish protective downstream 
immunity.  
  Following antigen capture in peripheral tissues, the activation and migration of mDCs 
into draining LNs is delayed for up to 18-24h to allow for transcriptional and translational 
modification, and a crawling migration sometimes representing distances of thousands of cell 
body lengths of the mDC.  In the case of vaccination, however, arrival of injected antigen is 
 53rapid, with detectable antigen arriving in the draining LN via the afferent lymphatics within 
minutes(Roozendaal et al., 2009; Gonzalez et al., 2010). This timing discrepancy between 
antigen arrival in the LN, and the migration of DCs from the periphery leaves open a potential 
window whereby targeting a vaccine to a non-degradative, immunostimulatory compartment 
within the LN could have important humoral immune ramifications.  
  Several studies have focused on the drainage of lymph-borne antigen from the afferent 
lymph into the subcapsular sinus of the draining LN(Szakal et al., 1983; Phan et al., 2007; 
Carrasco and Batista, 2007; Junt et al., 2007; Roozendaal et al., 2009; Gonzalez et al., 2010). A 
current view is that subcapsular sinus macrophages (SSMs) rapidly capture antigen from the 
lymph, and participate in its active transport to the B cell follicle. Less well described is the 
downstream filtration of the lymph within the medulla by medullary sinus-lining 
macrophages(Gray and Cyster, 2012) and LNDCs (Gonzalez et al., 2010). Historically, DC 
residing in the LN (LNDC) have been described as relatively sessile at steady state, (Steinman 
et al., 1997; Lindquist et al., 2004) and insufficient to drive effective immunity following direct 
antigen acquisition (Itano et al., 2003; Allenspach et al., 2008). The recent observation of direct 
viral capture in the medulla by the LNDC population, however, suggested they may have a more 
active role in the establishment of downstream immune response in the case of influenza 
vaccination(Gonzalez et al., 2010). 
  To extend our understanding of the role of LNDCs in establishing immune response to 
influenza vaccination, resident DCs were characterized at a whole-LN level. Unexpectedly, a 
major trans-nodal repositioning of LNDCs from the T cell cortex to the afferent medulla was 
observed within minutes of viral antigen arrival from the afferent lymphatics – areas recently 
shown to be important in vaccine efficacy(Liu et al., 2014). This migration leads to rapid viral 
acquisition by LNDCs and stimulation of viral specific naïve CD4+ T cells. Further, total 
elimination of skin mDCs had a negligible effect on the generation of a protective humoral 
response in mice vaccinated with UV-inactive virus.  Taken together, the results suggest a 
 54model where LNDCs are fully competent in establishing robust, long term viral immunity, even in 




Chapter 3.2 – Activation of LNDCs following influenza vaccination 
 
  To characterize LNDC response following vaccination, CD11c-eYFP C57BL/6 mice 
(Gerner et al., 2012; Hickman et al., 2008; Lindquist et al., 2004; Kastenmuller et al., 2013; 
Sung et al., 2012) were immunized subcutaneoulsy (S.C.) in the footpad with UV-inactivated 
Influenza-A virus strain PR8 (UV-PR8). DCs were tracked by multi-photon intravital microscopy 
(MP-IVM) of the popliteal lymph node (PLN) by surgically exposing the node in live, 
anesthetized mice(Kastenmuller et al., 2013; Gonzalez et al., 2010; Sung et al., 2012). 
Continuous imaging for 40 min following UV-PR8 vaccination revealed an influx of LNDC 
proximal to the collagen capsule (<150 um) (Fig 20a). Quantitation of cellular trafficking over 
this period identified a 3-4 fold increase in the number of YFP+ DCs within this region (3.23 ± 
0.24; p<0.001), suggesting a rapid repositioning to the periphery of the PLN . 
  In addition to increased cell number within the LN periphery, LNDCs exhibited extensive 
morphological changes over the 40 min imaging period (Fig 20a, inset). Measured in bulk, DCs 
within these regions increased in surface area by almost 50 percent following vaccination and 
experienced a concomitant increase in volume, and decrease in spherical index – a measure of 
the spherical nature of an object (Fig 20c), and data not shown).  Importantly, the fluorescence 
intensity of individual DCs did not change over this time period, indicating that the observed 
phenotypic changes were not due to changes in YFP expression. Together, these data suggest 
an unexpected accumulation and activation of resident DCs in the PLN periphery immediately 
following vaccination. 
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Chapter 3.3 – Repositioning of LNDCs to the medulla  
 
  In order to address the origin of the accumulating DCs, in vivo cellular tracking was 
applied to the live imaging model. By tracking individual DCs, it was observed that rather than 
infiltrating from an outside source, the cells originated from the interior of the PLN (>150µm from 
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Figure 20. LNDCs migrate to the medulla following influenza vaccination
(a) MP-IVM of DC arrival in the PLN periphery following UV-PR8 vaccination. Snapshots taken at 0 and 
36min post injection, and representative of 3 independent surgeries (3 mice) from different imaging sessions. 
Scale bars – 50µm. Inset: high magnification of two individual LNDCs (b) (left) Real time tracking of LNDCs 
from Fig1a. LNDC tracks highlighted (white) and final destinations marked (closed circle). Vector representa-
tion of complete tracks (right). Green and red vectors represent LNDCs with migration paths towards or away 
from the PLN capsule, respectively. Representative of 3 independent surgeries (3 mice) from different 
imaging sessions. Scale bar – 20µm (c) Quantitation of bulk DCs from live imaging in Fig 1a. DC spherical 
index (red) and surface area (black) displayed. ANOVA (black) p<0.005 ANOVA (red) p<0.005  (d) Fluores-
cent reconstructions of in vivo labeled CD11c-eYFP reporter PLNs. PLNs collected at 60 min following PBS 
or UV-PR8 vaccination. Representative of reconstructed 3 PLNs. Scale bars – 200µm (e) Quantitation of the 
















































































































36’the collagen capsule), which is beyond the imaging depth threshold for our imaging system (Fig. 
20b). Pretreatment of mice with CD62L blocking antibody, or local administration of Pertussis 
toxin, two approaches that limit influx of leukocytes from the vasculature or lymphatics, had 
negligible effect on DC accumulation (data not shown). These results provide additional 
evidence that the activated DCs originated within the PLN prior to vaccination and confirmed 
their identity as lymph node resident DCs (LNDCs). 
  To assess the overall movement of LNDCs following vaccination, 50 µm serial 
cryosections of PLNs were imaged by multi-photon microscopy (MPM), and serially 
reconstructed for analysis of whole PLNs.  Similar approaches were reported by Cyster and 
colleagues using confocal microscopy for partial PLN imaging(Groom et al., 2012; Grigorova et 
al., 2010). By in vivo labeling medullary macrophages (MMs) through pre-injection of an α-F4/80 
monoclonal antibody (mAb) into the footpad of CD11c-eYFP reporter mice, the medulla could be 
outlined and shown to include relatively sparse populations of LNDCs in resting naïve LNs (Fig 
20d). In agreement with the live imaging data, injection of UV-PR8 into the footpad of CD11c-
eYFP mice stimulated a visible shift of the LNDC population into the medullary compartment by 
60min post vaccination (Fig 20d). Flow cytometric analysis of single cell suspensions of PLN 
indicated no appreciable increase of LNDCs at these time points. This global repositioning of 
the LNDCs can be quantified through a shift in the ratio of medulla-occupying versus total 
LNDCs (Fig 20e). Migration data were further verified through MP-IVM, where the rapid arrival 
of LNDCs into the medulla could be observed. Surprisingly, this change in both LNDC 
morphology and localization could not be identified following the injection of traditional adjuvants 
such as Alum and MF59 despite extensive inflammation of the PLN, suggesting that this 






Chapter 3.4 – Capture of viral antigen by LNDCs within inter-follicular regions  
 
  Recent studies have identified interactions of DCs and T cells outside of the T cell area 
within inter-follicular regions (IFRs) in the stimulation of memory CD8+ T cell responses(Groom 
et al., 2012; León et al., 2012; Hickman et al., 2008; Sung et al., 2012). In these studies, central 
memory T cells were generated following viral infection with the purpose of tracking those cells 
in the LN after secondary challenge. Although there is debate on the resting location within the 
LN, it is clear that following secondary challenge, central memory CD8+ T cells are rapidly 
recruited to the IFRs where they undergo activation by antigen-loaded APCs. Further, a study by 
Hickman et. al. suggested a primary role for these sites in priming CD8 T cell immunity(Groom 
et al., 2012; Hickman et al., 2008). 
  We hypothesized that these sites may serve as destinations for migrating LNDCs. To 
characterize the architectural identity of the IFRs, PLNs were in vivo labeled with antibodies 
against the lymphatic endothelium (a-Lyve-1) and subcapsular sinus macrophages (a-CD169), 
and then optically cleared for MP imaging. Projections of whole nodes following optical 
clearing(Ertürk et al., 2012) identified long extensions of the medulla that protrude extensively 
between B cell follicles and merge with the subcapsular sinus. This observation identified two 
different types of IFR structure – cortical IFRs (cIFRs), which represent chemokine boundaries 
between the paracortex and B cell follicles, and medullary IFRs (mIFRs), which represent the 
most afferent connection points between the medulla and the subcapsular sinus (Fig 21a). 
Interestingly, these regions have recently been targeted by Liu et. al. (Nature 2014) in 
vaccination attempts, resulting in greatly enhanced T cell priming(Liu et al., 2014). Confocal 
imaging of mIFRs in PBS, or UV-PR8 vaccinated PLN identified YFP+ clusters similar to those 
identified in reconstruction analysis, identifying these sites as destinations for migrating LNDCs 
(Fig 21b). Histological staining confirmed that both CD11bhi, and CD8apos LNDC populations 
 58had accumulated in mIFRs within 60min of vaccination suggesting a multi-subset 
responsiveness to inactivated influenza (Fig 21b). 
  Afferent lymph flowing through the medullary sinus is constitutively filtered by sinus lining 
macrophages(Gray and Cyster, 2012), and this process predicts a natural gradient of viral 
antigen following vaccination. Thus, it is proposed that the highest antigen concentrations would 
reside at the tips of these mIFRs. To test this possibility, mice were injected S.C. with UV-PR8 
labeled with Alexa 633. Fluorescent PLN reconstructions at various time points identify 
accumulation of viral antigen within mIFRs over 6h following vaccination (Fig 21c). By contrast, 
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Figure 21. LNDCs infiltrate mIFRs and acquire viral antigen
(a) Schematic diagram of the architecture of a PLN. Medullary and cortical IFRs (mIFR and cIFR) are 
highlighted in red and blue respectively  (b) Confocal imaging of mIFRs in CD11c_eYFP PLNs 40min following 
vaccination with PBS or UV-PR8. Blue arrows: CD8apos DC; Red arrows: CD11bhi DC. Scale bars – 125µm. 
Representative of 3 independent trials; 3 mice/trial (c)  Reconstructions of in vivo labeled C57BL/6 PLNs 
vaccinated with A633-UV-PR8 and collected at 0.5, or 6h post-injection. White arrows: IFRs. Scale bars – 
200µm. Images representative of 3 independent experiments; 2 mice per time point per experiment. (d) MPM of 
in vivo labeled CD11c-eYFP PLNs 60 min following PBS or A633-UV-PR8 vaccination. Dashed line: IFRs. Scale 
bars – 40µm. Representative of 4 independent experiments, 2 mice per experiment (e) LNDC capture of 
A488-UV-PR8 by flow cytometry 60min post-injection.  (left) Cells displayed are pre-gated to be CD11chi. (n=4 
PLNs) (f) MPM of in vivo labeled CD11c-eYFP PLNs, 6hr post A633-UV-PR8 vaccination. Scale bar – 10µm. 























































































200µmlower levels of virus were retained in the subcapsular sinus and the deeper medullary 
compartments connecting with the efferent lymphatics. It was hypothesized that these antigen-
rich regions might serve as a destination for migrating LNDCs. High-resolution imaging of IFRs 
bearing dense deposits of viral antigen showed large numbers of infiltrating LNDCs within 60 
min of viral arrival at the node. Analysis of LNDCs by flow cytometry confirmed viral capture by 
both CD11bhi and CD8apos LNDCs within 30min post-injection (Fig 21e), which was verified by 




Chapter 3.5 – LNDCs present viral antigen to CD4+ T cells near IFRs 
 
  Previous work by Itano et. al. interrogated the role of migratory versus LN resident DCs 
in CD4+ T cell stimulation. In that study, soluble peptide designed for presentation on MHC II 
was injected subcutaneously, and downstream T cell responses were tracked in the draining LN. 
The authors observed two waves of peptide presentation – one at 6 hrs which resulted in only 
transitory activation, and one at 18 which stimulated a more robust, long term T cell response. 
The authors concluded that while resident DCs can activate T cells, the resident cells induce 
only a limited response with mDCs from the injection site required for robust immunity(Itano et 
al., 2003). To determine if LNDC participate in activation of viral specific CD4+ T cells within this 
study, CD11c-eYFP mice were adoptively transferred with labeled, ova-specific CD4+ OT-II T 
cells 24h prior to vaccination with a UV-inactive recombinant strain of PR8 (UV-PR8-OTII), 
which was engineered to express the OT-II epitope(Thomas et al., 2006).   
  As predicted, vaccination with UV-PR8-OTII stimulated activation of cognate T cells 
within 6h, as evidenced by CD69 up-regulation (Fig 22a). While individual DC-T cell contacts 




























Figure 22. Cognate CD4+ T cells relocate to mIFRs following 
vaccination  
(a) C57BL/6 mice received naïve OT-II T cells and were vacci-
nated with UV-PR8-OT2. OT-II T cell activation in PLNs was 
analyzed by flow cytometry. (n=4 mice) (b) CD11c-eYFP mice 
received labeled naïve OT-II T cells, and were vaccinated with 
UV-PR8-OT2. MPM of PLN 12h following vaccination. White 
arrows: LNDC/OT-II contacts. Scale bars – 50, 10µm. Represen-
tative of 3 PLNs; 2 independent trials (c) OT-II neighbor analysis 
of PLNs as shown in (b). Each symbol type represents an 
individual PLN, with 4 XY planes shown. (d) Heat map of OT-II 
neighbor counts as shown in (c). OT-II cells identified from 
images (left), and displayed with color indicative of the number of 
corresponding OT-II neighbors (right). Scale bars – 200µm (e) 
CD11c-eYFP recipients received labeled naive OT-II T cells and 
were vaccinated with UV-PR8-OT2. Fluorescent reconstruction of 
PLN, 24h following vaccination. T: T cell cortex, Per: PLN 
“periphery” . Scale bar – 100µm. Representative of 3 indepen-
dent trials; 2mice/trial (f) C57BL/6 mice received OT-II T cells 
and were vaccinated with UV-PR8-OT2. PLNs were collected at 
24hr following vaccination, optically cleared and imaged. Data 
represented with medulla isosurfacing to aid visual interpretation. 
White arrows: mIFR/T cell cluster colocalization. Scale bar – 
100µm. Representative 2 trials; 2mice/trial.was observed near IFRs by 12h 
following vaccination (Fig 22b). 
Additionally, small clusters of viral-
specific T cells could be identified 
surrounding LNDCs in these 
regions. To quantitate clustering, 
labeled, naive OT-II T cells were 
transferred into CD11c-eYFP 
recipients, which were 
subsequently vaccinated with UV-
PR8-OTII 12h prior to LN 
harvesting. The LNs were serially 
imaged for reconstruction, and 
single plane images were captured 
from each reconstruction, 
representing 400µm of vaccinated 
vs. control LNs. Using 
histocytometric analysis(Gerner et 
al., 2012), OT-II T cells were 
identified within each plane, and each T cell was assessed for the number of T cell “neighbors” 
present in the image within one T cell diameter. The resulting measure of T cell clustering 
revealed significant increases in the average number of T cell neighbors and increases in the 
absolute number of T cells with multiple neighbors within vaccinated vs. non-vaccinated LNs 
(Fig 22c). Significantly, heat mapping the number of T cell neighbors onto the original images 
identified the border between the paracortex and IFRs as the most densely populated by 
clustered T cells (Fig 22d). Analysis of T cell migration at  24h post-immunization identified 
 62
Fig 22, continueddiscreet clusters at the extremes of the paracortex, with specific co-localization of T cell clusters 




Chapter 3.6 – Clustering of viral-specific CD4 T cells is chemokine dependent 
 
  Previously mentioned studies describing central memory CD8 T cell responses within 
cIFRs have suggested the chemokine CXCR3 as a critical mediator of cellular retention in these 
regions. The ligands for CXCR3, CXCL9 and CXCL10, are produced by both hematopoietic and 
stromal cells in response to viral challenge, and are critical to CD8 T cell recruitment to these 
sites. (Kastenmuller et al., 2013; Sung et al., 2012). Additionally, Groom et. al. has recently 
described the upregulation of CXCR3 as an early first step in the generation of robust Th1 CD4 
T cell responses(Groom et al., 2012). Thus, we hypothesized that the clustering of CD4+ OT-II T 
cells with LNDC and virus in the IFR following immunization with UV-PR8 OTII could be 
CXCR3-dependent.  To examine whether CD4+ OT-II T cells become activated and differentiate 
to CXCR3+ T cells, LNs were harvested immunized mice and CD4+ T cells analyzed by flow 
cytometry for expression of cell surface markers of activation.  Notably, an increase in CD69 
expression on CD4+ OT-II T cells was observed, followed by a corresponding increase in CD44 
(Fig 23a, and data not shown). By gating on newly activated CD69+ cells, increases in CXCR3 
expression could be identified as early as 12h post-vaccination, and continued to increase over 
several days (Fig 23a,b).   
  As recent reporting has shown that activated DCs arriving from the periphery express 
CXCL10, and that direct injection of LPS/Poly I:C can induce CXCL10 expression within 12h in 
the draining LN(Groom et al., 2012), it was predicted that LNDCs might express this chemokine 




























Figure 23. CXCR3-dependent clustering of viral specific 
CD4+ T cells in mIFR
M: medulla, B: Follicles (a) Flow cytometry of OT-II T cell 
activation following UV-PR8-OT2 vaccination at indicated 
time points. (n=4) (b) Expression of CD69 (black) and 
CXCR3 (red) by OT-II T cells at indicated time points as in (a) 
CD69+ OT-II cells gated for CXCR3 expression analysis. 
Symbols represent individual mice. ANOVA (CD69) 
p<0.0005, ANOVA (CXCR3) p<0.005 (n=4) (c) CXCL10 
expression in vaccinated REX3 mice or unvaccinated REX3 
controls by flow cytometry. (left) displayed cells gated on 
CD11chi cDCs, followed by CD11bhi or CD8apos as 
indicated. (right) Percent CXCL10 positive DCs by subset 
(red: CD8apos; black: CD11bhi) following vaccination. (n=4) 
(d) MP imaging of REX3 PLN 24h following UV-PR8 vaccina-
tion. Dotted line: medulla. Representative of 4 PLNs from 2 
independent trials. Scale bars – 100µm. (e) Confocal imaging 
of REX3 PLN 24h following UV-PR8 vaccination. Arrows: 
CXCL10 positive DCs. Representative of 4 PLNs; 2 indepen-
dent trials. Scale bar – 32µm (f) C57BL/6 recipients received 
differentially labeled Wt, or CXCR3 deficient naïve OT-II T 
cells.  Recipients were vaccinated with UV-PR8-OT2, and 
PLNs were collected at 24h. Quantitation of clustering 
efficiency of wt, or CXCR3 deficient OT-II T cells shown. 
(n=5). (g,h) Adoptive transfers were carried out as in (f). 
Recipients were vaccinated, and PLN suspensions were 
collected 60h post-vaccination for flow analysis. Individual T 
cell populations compared to the same population in unvacci-
nated contralateral controls. CD40L (g) and CD69 (h) 
acquisition expressed as fold change in vaccinated, vs 
unvaccinated population controls. (n=5)within the IFR could explain the 
extensive clustering of CD4+ T cells 
observed within the antigen rich IFRs. 
To test this possibility, CXCL9/10 
reporter mice (REX3) (Groom et al., 
2012) were vaccinated with UV-PR8, 
and LNs were harvested after 24h for 
analysis by flow cytometry and immuo-
histochemistry (IHC). Flow analysis 
identified the expression of CXCL10 by 
both CD11bhi and CD8apos, LNDCs 
following vaccination (Fig 23c), 
although the CD11bhi population 
appeared more robustly responsive.  
Fluorescent reconstructions of 
vaccinated REX3 PLNs identified high 
CXCL10 expression on dendritic-
looking cells within mIFRs following 
vaccination suggesting LNDC 
expression (Fig 23d). Confocal analysis 
positively identified these cells as DCs 
through CD11c expression, and 
confirmed clustering of CXCL10-
positive DCs within IFRs by 24h 
following vaccination (Fig 23e). The timing of this event corresponded to both LNDC migration 










































































































































































































































































Fig 23, continued  To confirm the importance of CXCL10 in attracting viral specific T cells to the IFRs, mice 
were adoptively transferred with differentially labeled CXCR3+/+ and CXCR3-/- OT-II T cells and 
subsequently immunized with UV-PR8 OTII virus. Characterization of the vaccinated recipients 
revealed a significant defect in the clustering of CXCR3-/- OT-II cells at 24 h post-vaccination, 
confirming the importance of CXCR3 in T cell migration (Fig 23f). Additionally, flow cytometric 
analysis of CXCR3-/- OT-II T cells displayed a profound deficiency in both CD69 activation, and 
CD40L expression (Fig 23g,h). These results replicate reports by Groom et. al. which described 
early activation defects, followed by a deficient Th1 response in the absence of CXCR3. 
Together, these data suggest a model whereby LNDC activation of CD4+ T cells at early time 
points leads to expression of CXCR3, and contributes to the efficient localization of cognate 




Chapter 3.7 – LNDC dependent T cell activation  
 
  While the activation of T cells within 6 hours of vaccination suggested a role for LNDCs 
in early activation of CD4+ T cell responses to UV-PR8, it remained unclear if skin resident 
mDCs were required to establish an enduring humoral response. Employing a system 
developed by Itano et. al., the contribution of the migrating DC population could be effectively 
removed through resection of the injection site within 30min post-immunization(Hickman et al., 
2008; Itano et al., 2003; Lindquist et al., 2004; Kissenpfennig et al., 2005; Kastenmuller et al., 
2013; Sung et al., 2012). By administering UV-PR8 intra-dermally (I.D.) in the ear and removing 
the ear shortly following administration, the relative contribution of migrating DC and LNDC 
populations could be evaluated in the auricular LN (ALN).    
 66  Using this approach, C57Bl/6 mice were vaccinated with PBS or UV-PR8 I.D., with half 
of the vaccinated group undergoing ear removal (here referred as the van Gogh, or vG group) 
within 30min following vaccine administration. Using REX3 reporter mice, expression of 
CXCL10 by both CD11bhi and CD8apos in Wt, or vG 
vaccinated animals was assessed 24h following 
injection/resection. Interestingly, while CXCL10 
expression was still robust in both LNDC populations 
suggesting normal responsiveness to vaccination 
despite a lack of mDCs in the vG group (Fig 24a), 
there was a small decrease in expression by the 
CD8apos subset, perhaps relating to its known reliance 
on incoming mDCs from the periphery(Gonzalez et 
al., 2010; Allan et al., 2006).  
  By transferring CFSE labeled naïve OT-II T 
cells into B6 recipients, and employing the vG 
vaccination system, potential deficiencies in T cell 
proliferation and activation could be assessed in the 
absence of mDCs from the injection site. Surprisingly, 
vG group OT-II T cells proliferated similarly to the Wt 
group (Fig 24b), and could be tracked through 7 
divisions in 60h. Tracking T cell activation by division 
status, cells could be observed acquiring both CXCR3 
and CD40L as they proliferated in both the Wt and vG 
groups (Fig 24c,d). Interestingly, while CD40L 
expression appeared identical in both groups, there 
was a slight delay in CXCR3 acquisition between the 
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Figure 24. mDC independent LNDC/CD4+ 
T cell activation
Ear resection in the van Gogh (vG) model 
30min following vaccination. (a) Percentage 
of CD8a+ (light gray), or CD11bhi (dark gray) 
cDCs in the ALN 24h following ear vaccina-
tion. PBS, Wt, and vG groups displayed. 
ANOVA (light gray) p<0.0001; ANOVA (dark 
gray) p<0.0001. (n=4) (b) CFSE labeled OT-II 
T cells were transferred into C57Bl/6 recipi-
ents. Recipients were vaccinated in the ear, 
and separated into Wt, and vG groups. ALNs 
were isolated at 60h post injection, and 
analyzed by flow cytometry. (left) Percent 
OT-II T cells by division number as assessed 
by CFSE dilution. ANOVA p>0.1. (right) 
Representative plot of CFSE dilution in Wt, 
and vG groups (n=4 mice/group). (c,d) 
adoptive transfers were established as in (c). 
OT-II T cell expression (MFI) of CXCR3 (c) 
and CD40L (d) was assessed by T cell 
generation to track acquisition over time. 
Two-way ANOVA (c) p<0.0001 overall, 
p<0.05 between groups. Two-way ANOVA (d) 
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hiWt, and vG group. These findings may also suggest collaboration with mDCs in reinforcing Th1 
immunity development as they arrive from the periphery.  
 
Chapter 3.8 – LNDC dependent B cell memory   
  As LNDC, and T cell activation appeared to be intact despite the absence of mDCs in 
the vG model, it was hypothesized that LNDCs may be sufficient to drive downstream protective 
humoral immunity despite the absence of mDCs. To test this hypothesis, the vG vaccination 
model was employed in C57Bl/6 mice alongside PBS vaccinated controls. ALNs were collected 
at d7 following vaccination, and germinal center staining appeared normal in both Wt, and vG 
groups confirming effective T cell help despite the absence of mDCs (Fig 25a). Ab titers 
collected at d10 following vaccination showed normal increases in IgM, IgG1, and IgG2b in vG, 
versus Wt vaccination groups in comparison to unvaccinated controls suggesting normal class 
switching and germinal center development(Fig 25b).  
  To test the functionality of this antibody response, vaccinated, or unvaccinated controls 
were challenged I.T. with a lethal dose of live PR8 on d21 following vaccination. Morbidity was 
monitored for 9 days post infection, at which point the unvaccinated control group was sacrificed 
due to excessive weight loss. Neither Wt, and vG groups experienced significant weight loss 
over the course of infection, indicating protective immunity had been generated with, or without 
mDC arrival from the injection site (Fig 25c,d). Finally, antibody titers were assessed at day 9, 
and compared to both unvaccinated, and uninfected controls. As expected, Ab titers showed 
extensive class switching in both Wt, and vG groups, and protective IgG2b responses were 
identical between groups. It is worth noting that while not required for protection, IgG1 Ab titers 
were slightly, but insignificantly decreased in the vG group providing additional evidence for 
LNDC/mDC collaboration in a vaccination setting. Altogether, these data demonstrate that 
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Figure 25. mDC independent protection from influenza
(a) Confocal imaging of ALN follicles at day 10 following UV-PR8 vaccina-
tion in Wt, and van Gogh (vG) mice. Dotted line: B cell follicle. Scale bars – 
100µm. Representative of 2 independent trials; 5mice/group (b) ELISA 
analysis of PR8 specific serum antibodies at day 10 following UV-PR8 
vaccination. Relative titers of PR8 specific IgM, IgG1, and IgG2b shown. 
Symbols represent individual animals (c) Unvaccinated, or vaccinated Wt, 
or vG groups were challenged with LD80 PR8 21 days following vaccina-
tion. Morbidity (left) and mortality (right) displayed as percent body weight, 
or percent survival respectively. 6 mice/group (d) ELISA analysis of PR8 
specific serum antibodies at day 9 following PR8 challenge as in (c) 
compared to naive C57Bl/6 littermates. Relative titers of PR8 specific IgM, 
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p = 0.0010Chapter 3.9 – Discussion  
  
  Earlier studies identifying capture of lymph-borne inactive influenza virus by LNDC 
raised the question of the relative importance of this population in overall humoral immunity.  To 
gain a broader understanding of LNDC in response to vaccination with inactive influenza, a 
whole-node imaging approach was developed and mice bearing a fluorescent reporter for DCs 
(CD11c+) were vaccinated with UV-PR8.  Following sub-cutaneous vaccination, viral antigen 
was observed within the draining LN within minutes as expected.  Surprisingly, however, the 
virus accumulated over the first six hours within specialized sites identified as medullary IFRs.   
 
Using fluorescent reconstructions of full PLNs isolated at early time points following vaccination, 
we observed a major repositioning of LNDC from the T cell cortex to the medullary IFR where 
they acquired viral antigen and became activated. This was unexpected since LNDC are 
reported to be relatively sessile at steady state.  The capture of virus by the resident DC was 
biologically relevant since they became positive for the chemokine CXCL10 and formed clusters 
with viral-specific CD4+T cells that became activated based on expression of CD69 , CD44 and 
CXCR3.  Thus, three lines of evidence are presented that support a role for LNDCs in promoting 
a humoral response to inactive PR8 independent of migrating DCs: (i) activation of viral specific 
CD4+ T cells prior to expected arrival of skin migratory DC; (ii) activation of viral-specific CD4+ 
T cells within PLN in the absence of mDCs; and (iii) a normal humoral memory response 
despite surgical removal of the injection site within 30min of vaccination. Notably, while these 
findings clearly demonstrate sufficiency of the resident DC population in establishing humoral 
immunity, they do not address the requirement of migrating DCs under conditions where lymph 
borne antigen is not readily available. 
  While several groups have previously described resident DC populations in skin draining 
LNs(Grigorova et al., 2010; Lindquist et al., 2004), few have directly assessed their potential in 
presenting antigen acquired directly from the lymph. In one study, Itano et. al. describe a two 
step process of antigen presentation where resident DC in the LN were capable of acquisition 
 70and presentation of soluble peptides, but skin resident mDCs were required for effective 
immunity.  In another study, Allenspach et. al. found that in the case of soluble peptide 
administered with CFA, resident dendritic cells were similarly deficient in T cell 
presentation(León et al., 2012; Allenspach et al., 2008; Hickman et al., 2008; Sung et al., 2012). 
Our findings are not inconsistent with these results, as the robust activation/migration of resident 
dendritic cells cannot be identified following traditional adjuvant administration (alum or MF59). 
The profound differences in these responses also raises interesting questions about a potential 
gap between traditional vaccination approaches, and natural response to viral antigen. As 
medullary macrophages rapidly degrade protein antigen as a part of normal lymphatic filtration, 
it is important to understand how to maximize antigen exposure to efficient antigen presenters – 
especially when antigen concentration is highest immediately following vaccination. Data from 
this study suggest that LNDCs are capable of effectively utilizing antigen when appropriately 
stimulated, and could represent an efficient target for vaccination approaches.  
  An unexpected observation was the rapid kinetics of LNDC repositioning from the 
paracortical region to the medullary IFR in response to localization of viral antigen. While large 
deposits of LNDCs were observed in viral-loaded IFRs within hours of vaccination, individual 
LNDC morphological changes could be observed within 12 minutes of vaccination. The highly 
directional migration pattern of LNDC to the sites of viral accumulation suggests a response to 
chemotactic mediators released from a pre-stored source following innate sensing of viral 
antigen, although this source remains yet unclear.    
  Recent, studies have identified CXCR3 and its ligands CXCL9 and CXCL10 as required 
for migration of CD8 memory T cells into IFRs where they make contact with both antigen and 
APCs. While the distinction between medullary and cortical IFRs was not made in these studies, 
it is clear that this chemo-attractant is important in various conditions of immune response.  In 
our study, formation of clusters of viral specific CD4+ T cells with LNDC was significantly 
reduced in CXCR3-/- OT-II T cells.  Since CXCL10 expression is not restricted to LNDCs, this 
pathway might provide an efficient mechanism for collaboration between LNDCs and incoming 
 71mDCs, whereby early activation of naïve CD4 T cells, and concomitant expression of CXCR3, 
allows activated T cells to more easily find mDCs from the injection site which also express 
CXCL10. Additionally, it is possible that mDCs might be able to locate hot spots of immune 
activation within the LN through their own expression of CXCR3. 
  In summary, using novel whole node imaging approaches, we observed a multistep 
system of immune activation whereby viral antigen, LNDCs, and cognate naïve CD4+ T cells 
rapidly assemble in highly organized environments within the draining LNs known to be relevant 
to vaccine design (Hickman et al., 2008; Liu et al., 2014).  In addition to identifying an 
unexpected repositioning of LNDCs to specialized sites within the draining LN, these findings 
clarify the importance of CXCR3 in establishing immunostimulatory microenvironments in three 
dimensions, and establish LNDCs as biologically relevant cell populations – sufficient to drive 
humoral memory response to an influenza vaccine in the absence of migratory DCs. 
 
Chapter 3.10 – Materials and Methods 
 
Animals. Mice used in this study were bred and housed in standard conditions and used 
between 6-12 weeks of age. All experimental protocols approved through Harvard University’s 
Institutional Animal Care and Use Committee. 
 
In vivo labeling. In vivo labeling of the PLN subcapsular sinus and medulla was achieved 
through injection of alexa conjugated (A488, A568, A633) antibody targeting stromal (a-LYVE-1) 
or macrophage populations (a-CD169, a-SIGNR1, a-F4/80) S.C. in the footpad 4 hours prior to 
PLN imaging or tissue harvest.  
 
PLN live imaging. PLN live imaging was carried out through surgical exposure of the PLN in 
anesthetized mice, and MPM. Temperature was monitored using a digital thermometer 
 72embedded in the imaging chamber created around the PLN, and controlled using a closed-
circuit water circulation system(Ertürk et al., 2012; Lindquist et al., 2004; Gonzalez et al., 2010).  
 
Three-dimensional reconstruction. Collected organs were fixed in 4% PFA, embedded in 
OCT and serially cryosectioned (50um). PLN sections were serially imaged by MPM, and 
assembled using Imaris software to obtain 3D reconstructions. Final analysis was carried out 
using Volocity image analysis software. 
 
Whole organ imaging. Lymph nodes were dissected and fixed overnight in 4% 
paraformaldehyde. The sample was then incubated in increasing concentrations of 
tetrahydrofurane followed by dichloromethane. Finally, the PLN was immersed in BABB (benzyl 
alcohol: benzyl benzoate-mix 1:2) for final clearing and imaging. (Liu et al., 2014; Lindquist et 
al., 2004; Ertürk et al., 2012). 
 
Viral propogation/labeling. Influenza virus was grown in live chicken eggs, purified over 
sucrose gradients(Gray and Cyster, 2012; Gonzalez et al., 2010; Szretter et al., 2006), and 
labeled using standard alexa-labeling protocol (Invtrogen). 10-20μl sub-cutaneous injections 
were given in the footpad at 1x106 pfu.  
 
T cell isolation. LNs of OT-II mice were processed using Liberase DH (Sigma) digestion, and T 
cells isolated through MACS negative selection (CD11c, CD11b, NK1.1, B220, GR-1, CD69, 
CD8). T cells were labeled in 10um CMTMR for imaging, or 5uM CFSE for imaging and flow 
cytometric identification. 1 or 5x10^6 cells were adoptively transferred into naïve recipients for 
flow cytometric, or imaging experiments respectively. 
 
3 dimensional image analysis. Images processed and analyzed using Volocity imaging 
software. Histocytometric analysis of reconstructions was performed with CellProfiler(Itano et 
 73al., 2003; Grigorova et al., 2010; Carpenter et al., 2006), and CellProfiler Analyst(Thomas et al., 
2006; León et al., 2012; Jones et al., 2008; Hickman et al., 2008). Analysis of reconstructions  
were carried out with individual XY imaging planes, which were representative of at least 400um 
of reconstructed LNs.  
 
T cell clustering. CXCR3 -/- and Wt OT-II cells were isolated as above, differentially labeled, 
and adoptively transferred into C57BL6 recipients. PLNs were collected, processed and serially 
imaged 24h after vaccination with UV-PR8-OT2. T cell clusters were identified using a blinded 
approach, and the percentage of each population within these clusters was measured. 
 
Ear resections. Ear removal carried out 30min following injection of 10ul PBS or UV-PR8 S.C. 
between the ear dermal layers. ELISA analysis of serum was carried out through immobilization 
of UV-PR8 on the plate, addition of serum, and probing for specific binding of IgM, IgG1, or 
IgG2b 
 
Statistics. All statistics/graphical representations of collected data assembled through Prism. 
Mean, SEM displayed where applicable. Results from Student’s T tests , or Tukey post-testing, 
indicated by asterisks in figure (*p<0.05, **p<0.005, ***p<0.001) . One-way, or Two-way ANOVA 
testing indicated in legend.  
 
Chapter 3.11 – Author contributions     
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Chapter 4      
 General discussion 
                                                 
 75Chapter 4.1 – Empiricism in vaccination 
 
  Chinese history suggests that by 1000 CE, vaccination was already being investigated 
as a viable tool for the control and prevention of infectious disease. As early western attempts to 
vaccinate against smallpox (largely credited to William Jenner in 1796) pre-dated the 
acceptance of germ theory by at least fifty years, vaccinology at its core is deeply rooted in 
empirical study. Despite a lack of mechanistic understanding surrounding vaccine development, 
human vaccination programs have been hugely impactful in reducing morbidity and mortality 
worldwide. The crown jewel of these programs, the successful worldwide eradication of variola 
virus, eliminated the leading cause of death among Europeans in the 18th century. Similar efforts 
are currently underway to eradicate polio from the human population, and incidence of serious 
diseases such as measles, mumps, yellow fever, and influenza has decreased markedly in 
areas with robust vaccination programs. It is the success of these programs that led then-US 
Secretary of Health and Human Services, Margaret Heckler, to announce in April of 1983 that 
the HIV virus had been discovered, and that a vaccine would be ready for testing within 
approximately two years.  
In fairness, the first NIH approved vaccine trial for HIV was initiated in 1987, only four years 
after the announcement. That vaccine, however, demonstrated little to no efficacy in the 
prevention of HIV/AIDS(Controversial AIDS vaccine fails to delay disease., 1996). Similarly 
ambitious targets including malaria and dengue fever – both extremely deleterious to 
economically disadvantaged societies – have shown little progress in almost 40 years of 
research. This unexpected failure to achieve meaningful protection against some of humanities 
most notorious pathogens is seemingly at odds with the explosion of new technology currently 
being employed by the vaccination field. Recombinant DNA technology, reverse genetics, 
employment of nanomaterials, and even gene therapy have made gains in the prevention of 
human disease, but failed to adequately address these major health concerns. Somewhat 
surprisingly, the lack of success in these areas has had little impact on the empirical nature of 
 76vaccine development, resulting in few resources spent developing basic understandings of the 
contextual requirements for vaccine efficacy. 
In his landmark address to the Cold Spring Harbor symposium in 1989, Charles Janeway 
argued for a view of immunological activation where simple recognition of foreign antigen is not 
sufficient to drive robust immune response. In it, he asserted that the immune system must have 
a way to distinguish between pathogenic and non-pathogenic foreign antigen, and coined the 
term ‘pathogen associated molecular pattern’. Since that address, the field of innate immunity 
has undergone a renaissance in the discovery of a plethora of signals that the immune system 
uses to determine when, and how to respond to an incoming pathogen. From Toll-like receptors, 
to RIG-I like receptors, to inflammasomal signaling in response to danger associated molecular 
patterns, innate immunity has developed as a critical context for adaptive immune activation. 
However, even this context remains incomplete. 
The lymph node even at rest is a chaotic, yet highly organized environment where the 
adaptive immune system rapidly scans the ‘antigen library’ from draining tissue for potential 
matches, before moving on to the next lymph node where it will repeat the process. These 
scanning functions are made possible by the underlying lymph node stroma, and are co-
ordinated by the chemokine gradients that they produce. Normal filtration functions within the 
lymph node quietly sequester protein and cell-debris, and dendritic cells from the periphery 
periodically find their way into the environment to help promote peripheral tolerance.  In the 
case of vaccination, however, this picture can change dramatically. The major objective of this 
study has been to understand the context of the hematopoietic system within the lymph node 
environment, and understand how changes within that context directly impact the quality and 





 77Chapter 4.2 – Stromal influence on vaccine success   
  The lymph node stroma serves as the basic cellular infrastructure of the lymph node 
environment. This study has described the dependency of the hematopoietic compartment on 
the FRC network, and previous studies have assessed the importance of other stromal cell 
types on immune function(Allen and Cyster, 2008; Malhotra et al., 2012a; Cohen et al., 2010). 
Further, disruption of these populations, either by infection or genetic modeling, results in 
profound deficiencies in immune function at steady state, as well as decreased vaccination 
efficacy(Wang et al., 2011; Estes, 2013). Despite this strong interconnection between the 
stromal and hematopoietic compartments, many basic questions about those interactions occur 
still exist. 
  An emerging theme in the stromal field is the concept of stromal flexibility. While the 
stroma in general has long been viewed as steady directors of lymph node organization and 
homeostasis, new data suggests that the stroma may actually be a dynamic environment(Wu et 
al., 2009; Jarjour et al., 2014). The discovery of functionally distinct LEC populations in the 
subcapsular sinus, defined by their attachment to the ceiling or the floor, suggests that these 
cells must be responding to signaling differences which exist within the span of only 10µm of 
sinus lumen(Ulvmar et al., 2014). The requirement for fluid flow for expression of CCL19 by 
FRCs in ev-vivo cultures raises the question of whether mechanoreceptor signaling may be a 
common theme in stromal population function and responsiveness(Tomei et al., 2009). Finally, 
this study describes functionally distinct subsets of FRCs, which seem to differ primarily by their 
geographic location within the lymph node. This brings up the question of how FRCs ‘know’ to 
express BAFF only in the context of the B cell follicle. 
  As previously described, subcapsular sinus macrophages perform extremely specialized 
functions in their ability to respond to viral infection, and serves as critical mediators of antigen 
hand off to underlying B cells(Carrasco and Batista, 2007; Junt et al., 2007; Martinez-Pomares 
and Gordon, 2012). Perhaps unsurprisingly, they can only be found in the subcapsular sinus 
 78where this antigen hand off to B cells would be functionally useful. More unexpectedly, however, 
is the finding that these cells require B cells, and specifically LtB signaling, in order to acquire 
these specialized properties(Moseman et al., 2012). Interestingly, unpublished data surrounding 
FRC differentiation in vitro suggests that these stromal cells may also be responsive to LtB 
signaling, which offers a potential explanation for the restriction of BAFF expression by FRCs 
only in the B cell follicles. This sort of crosstalk between stromal and hematopoietic populations 
raises clear questions about how other stromal populations might be modifying their function 
depending on local hematopoietic signaling. Could responsiveness of LECs to LtB or other 
follicular signaling explain the difference between ceiling LECs and floor LECs? Are MRCs 
similarly responsive to their surrounding environment? Perhaps more importantly, could 
confusion surrounding cross expression surrounding ‘MRC markers’ on other stromal 
populations be clarified through the realization that expression of these markers are externally 
dependent? 
  While it may be interesting to speculate on how these populations interact at steady 
state, an even more intriguing question might be how stromal populations respond to the 
inflammation generated following vaccination. FRCs have already been described as 
responsive to signaling molecules required for effective immune response(Lukacs-Kornek et al., 
2011), and the role of FDCs in the generation of germinal centers critical for humoral immunity 
has been well described(Allen and Cyster, 2008). Despite this, little data exist surrounding how 
stromal phenotypes are altered following various inflammatory stimuli (Malhotra et al., 2012b). 
With recent studies even suggesting that certain stromal populations might serve as antigen 
presenting cells(Cohen et al., 2010; 2014), the vaccination field can no longer afford to overlook 
the impact that the stroma has on the success or failure of specific vaccination approaches 




 79Chapter 4.3 – Lymph flow and immune response   
  In addition to the cellular signals that the stroma provides, it is also responsible for the 
maintenance of the structural integrity of the lymph node through the production of the vast 
conduit network(Gretz et al., 1997; Mueller and Germain, 2010; Turley et al., 2010; Katakai et 
al., 2004). Often discussed in terms of antigen delivery, the collagen network also serves as the 
substrate for leukocyte migration within the node(Bajénoff et al., 2006; 2007), as well as a direct 
line of lymph flow through the paracortex(Gretz et al., 1997; 2000; Roozendaal et al., 2009). 
This lymph flow function of the conduit network, although not yet well understood, is particularly 
intriguing in the ability of the lymph node to respond to an upstream infected environment. 
Whether through the activation of mast cells at an infection site(Kunder et al., 2009), or the 
release of chemokine signals designed to draw in inflammatory monocytes(Palframan et al., 
2001; Nakano et al., 2009), the conduit network might serve as a way to allow chemical signals 
to penetrate deep into the lymph node without sacrificing barrier integrity. 
  One of the most exciting phenotypes that have been identified in the current study is the 
activation, and rapid mobilization of the LNDC population following inactivated influenza 
vaccination. When injected into the footpad, inactivated influenza-A arrives in the PLN within 5 
minutes under normal conditions. Once it has arrived, almost instantaneous changes in 
morphology can be seen in the LNDC population, and directional migration can be identified 
deep within the paracortex within 10 minutes of vaccine administration. Though neither the 
signal, nor the signaling cell have been identified to-date, the dramatic speed in which this 
response plays out suggests a number of features of the signaling cascade. First, the signal is 
likely to be pre-stored as the 5 minute window leaves little time for transcription or translation of 
a novel chemotactic agent. Second, the signaling cell is very likely responding directly to the 
virus prior to chemotactic release. As the TLR/RLR/DAMP signature of influenza is well 
established(McGill et al., 2009), one could reasonable hope to narrow down the molecular 
trigger, and use that information to identify potential cellular candidates capable of responding to 
 80those signals in the lymph node. Finally, regardless of the kind of signal, it must be capable of 
penetrating deep into the paracortex where it can first stimulate LNDC populations. 
  The penetration of such rapid signaling from the medulla to the paracortex is difficult to 
explain without an efficient mechanism of signal transduction through the lymph node. While it is 
possible that simple diffusion through the parenchyma may play a role, it seems more likely that 
there is a path of lesser resistance than the packed lymph node environment. If the conduit 
network does indeed play an important role in carrying these signals through the node more 
efficiently, then the rate of fluid flow through the system might play an important role in the 
stimulation of immune response. 
  Although early studies looking at lymph flow and composition were able to establish 
basic parameters of how lymph flows through a node(Browse et al., 1984; Sainte-Marie et al., 
1982), little work has been done on the effect of lymph flow on immune response. One of the 
earliest findings, that protein from the lymph is concentrated from afferent to efferent at the 
lymph node site(Knox and Pflug, 1983), has a potentially profound impact on the idea of antigen 
delivery within a vaccination model. These findings, in association with the idea that fluid flows 
‘downhill’ into the lymph node vasculature(Gretz et al., 2000), suggests that small chemical 
signals may not only enter into the deep paracortex of the lymph node, but may even be able to 
stimulate the host organism systemically through the dissemination of soluble signals into the 
blood. This hypothesis may be difficult to reconcile at steady state, when the size cutoff of 
molecular entry into the vessels hovers around 2kD, but little is known about the effect of heavy 
inflammation on fluid dynamics in the lymph node. Could vasodilation in the lymph node lead to 
dissemination of activating signals into the blood? Could this help explain the mobilization of 
cells from the bone marrow in response to a segregated peripheral response?  
Early collaborative studies based on these ideas have begun to identify an axis of fluid flow 
where flow direction from the vessels to the lymphatics (or vice versa) might hinge on relative 
fluid pressures from both inputs. Hopefully, as new imaging systems are able to capture these 
systems at higher detail, a greater understanding of how the flow environment might serves to 
 81influence immune response will develop. Regardless, continued investigation into these sorts of 
basic physical systems, the conduit system in particular, should be considered a high priority in 
truly understanding the context of immune activation. 
 
 
Chapter 4.4 – Dendritic cells in vaccine immunity   
While the stromal and structural components of the lymph node have an important role in 
the induction of protective immunity, the hematopoietic system must still be considered the 
central player in immune response. The innate immune systems ability to differentially respond 
to external stimuli, and to create micro environments which are able to correctly activate and 
educate the adaptive system makes it clear that understanding exactly how, and under what 
circumstances these micro environments are created may be essential in guiding successful 
vaccination. This study lays out an example of this kind of microenvironment creation in the 
rapid mobilization of LNDCs, and the recruitment of CD4+ T cells to antigen rich sites via the 
production of CXCL10. While this is an exciting first step in understanding the earliest 
responses to influenza vaccination, many questions still remain. 
As previously discussed, early studies on LNDCs described a population that were relatively 
sessile, and had little ability to generate an effective downstream protective response(Itano et 
al., 2003; Lindquist et al., 2004). This view of these populations is in obvious conflict with the 
current study, however this conflict can be easily reconciled by assessing the methods used to 
initiate immunity. Although this study does not directly address the trigger signals for LNDC 
activation and migration, anecdotal evidence to date has suggested that this rapid response 
does not occur under all inflammatory situations. Even traditional adjuvants such as alum and 
MF59 do not seem to stimulate this population despite causing large scale inflammation and 
immune response. Although at face value this seems surprising, it is perhaps less so when 
considering the role of dendritic cells in the initiation of immunity.  
 82Two defining roles of the dendritic cell population as a whole are their ability to present 
antigen, and their ability to educate adaptive immunity to shape an effective response. Both of 
these roles depend heavily on their ability to sense and respond to their surrounding 
environment, and relay that information appropriately. Careful studies across dendritic cell 
subsets have resulted in great variation of function, and the understanding that individual DCs 
populations have different capacities in response to the same stimuli(Desch et al., 2011; 
Jakubzick et al., 2008; Shklovskaya et al., 2008). Furthermore, variations in stimuli alter the way 
that individual DC populations will respond and present antigen(Stoitzner et al., 2005).  
  In this study, the responsiveness of LNDCs to influenza vaccination is assessed, and is 
shown to initiate Th1 immunity. While this finding is exciting, and suggests that these cells might 
be targeted for effective vaccination, it would be inappropriate to assume that this ‘type’ of 
activation is the only method of response that they are capable of, or even if it is an ideal 
outcome for long lasting immunity. While this system appears to stimulate a robust Th1 
response, one could easily imagine a different scenario where these cells contribute to Th17, or 
even toleragenic responses depending on the associated PAMP or DAMP signatures. Likewise, 
migratory DC populations have similar plasticity, which has led to conflicting reports in the role 
of individual populations in stimulating adaptive immunity(Lutz and Schuler, 2002). Rather than 
attempting to pigeonhole these populations into immutable roles, it is perhaps more useful to 
think about the dendritic cell system as one where evolution has selected for multiple DC 
populations, all working in tandem, differentially responding and collaborating to shape a 
complete, well directed immune response. In this way, the question ‘What do LNDCs do during 
vaccination?’ is more appropriately replaced with ‘How do LNDCs respond to selected stimuli, 
and how can those stimuli be used to shape immunity in the case of vaccination?’. 
In summary, this study attempts to further understand the context in which immune 
response to vaccination occurs. Focusing on the collagen structure and conduit network, the 
foundation of how lymph flow, and thus signal transduction, might influence immune responses 
both locally and systemically might be laid. Looking to the stroma, understanding how FRCs 
 83direct homeostasis of the adaptive immune system in secondary lymphoid organs, but also their 
indispensability for effective humoral immunity has been established. Finally, by addressing the 
role of LNDCs in response to influenza vaccination, a view of how the hematopoietic system 
generates stimulatory micro environments, even within the lymph node, for the generation of 
protective humoral has begun to emerge. Altogether, this work represents the early stages of 
the much broader question of how physical, stromal, and immune systems come together to 
generate immune response. Ultimately, the answer to those question might enable the 
manipulation of those systems, in the larger goal of generating and shaping immune responses 
against specific human pathogens. 
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